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ABSTRACT 
MESP1 is a basic helix loop helix transcription factor that is essential for the 
survival and development of mouse embryogenesis. It is the earliest marker for 
identifying the nascent mesoderm that is fated to becoming the myocardium, head 
mesenchyme, and somites. In spite of the advancements in our knowledge of 
MESP1, it is, however, still very unclear how it directs the activation of the cardiac 
program. It is important to understand MESP1’s epigenetic, and transcriptional 
function during development to increase efficiency in somatic and stem cells 
cardiac reprogramming. ChIP-seq analysis of endogenous targets of 
endogenously expressed MESP1 affected neuro-ectoderm specific GO terms over 
mesendoderm specific terms predominantly. To analyze MESP1’s effect on target 
genes, a comparison to RNA-seq data of FACsorted YFP cells from ESC and day 
5, 6, 7, and 8 was done. YFP protein marks endogenously activated MESP1 
expressing cells during EB differentiation which resulted in identifying MESP1’s 
effect on target genes. Analysis of the transcriptome of YFP positive cells provided 
evidence that MESP1 is indirectly activating the core cardiac program and directly 
repressing the non-mesoderm program such as neuro-ectoderm. MESP1 directly 
represses the neuro-ectoderm developmental program by targeting, Sox2, 
Neurod1, Neurog1, Neurog2, and Neurog3 by reducing the expression levels 
within the first 12 hours of Dox induction. Meta-data analysis of MESP1-binding 
regions with H3K27acetylation and tri-methylation show strong overlap with 
H3K27acetyaltion favoring Mesendoderm specific genes and H3K27me3 favoring 
neuro-ectoderm target genes. H3K27acetylation suggest a potential mechanism 
vii 
 
 
in indirectly activating the core cardiac program. ChIP-qPCR of Neurog3 adjacent 
enhancers show that MESP1 guides the deposit of H3K27me3 through the PRC2 
complex in an ebox variant-dependent manner.  Analysis of MESP1 binding sites 
for potential bias in the ebox variant show that CACCTG variant is favored in 
regards to both repressive function and H3K27me3 marking,.
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1. Chapter 1 Literature Review  
 
The discovery of Mesp1 in 1996 by Dr. Yumiko D. Saga from the Banya 
Tsukauba Research institute in Ibaraki Japan has open the door for decades of 
research in understanding the developmental process of cardio-myogenesis 
(Saga, Hata et al. 1996). More than over 800 peer-reviewed articles have been 
published on MESP1 biogenesis, regulation, and obligatory role in the formation 
of cardiac lineages. Thus, Dr Saga’s seminal discovery was an important 
achievement in contemporary developmental biology. Recent studies also 
revealed that populations of Mesp1-marked ES cells may hold the key to 
understanding how embryonic stem cells become cardiac progenitor lineages. 
There is a great urgency today to replace damaged cardiomyocytes with new 
myocytes from reprogrammed adult mesenchymal stem cells and or somatic cells. 
Thus, understanding MESP1’s functional biological role is essential for generating 
new insights in regenerative medicine. 
Cardio-myogenesis and the developmental appearance of the heart begins 
during the earliest stages of embryogenesis being the first mesodermal organ to 
appear after gastrulation. MESP1 and its importance in embryogenesis, requires 
an understanding of gastrulation and the formation of the mesodermal germ layer. 
Gastrulation is the process of producing the three germ layers from the 
single-layer blastula. Each germ layer (ectoderm, mesoderm, and endoderm) 
further develops to give rise to distinct tissues of the organism. The initiation of 
gastrulation is marked by the formation of the primitive streak, located on the 
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surface of the blastula towards the posterior regions of the embryo (Read, Bedford 
et al. 1970, Kennison 2002, Wild and Fleming 2002). Mesoderm formation begins 
at the junction of the epiblast and the extraembryonic tissue where Dr. Saga 
discovered the appearance of Mesp1. The primitive streak extends down the 
midline, establishing both the bilateral symmetry and posterior-anterior axis, and 
the ingression of the mesoderm and endoderm progenitors begins and the 
formation of the three germ layers occurs (Kinder, Tsang et al. 2001). 
When the three germ layers are established, they will begin to elaborate 
into distinct parts of the organism. The ectoderm germ layer will further differentiate 
into the surface ectoderm, neural crest, and neural tube (Tuchmann-Duplessis, 
David et al. 1971, Stern 2005). The germ layer endoderm contributes to all the 
inner epithelial lining of the digestive tube, and the lining of all glands of the 
digestive tubes, and stomach, colon, liver, pancreas, and the urinary bladder. The 
endoderm also contributes to the epithelial lining of the trachea, lung, pharynx, 
thyroid, parathyroid, and intestines (Wells and Melton 1999, Kimelman and Griffin 
2000, Rodaway and Patient 2001, Hogan and Zaret 2002, Technau and Scholz 
2002, Zorn and Wells 2009, Goessling and Stainier 2016). The mesoderm layers 
that lies between the ectoderm and the endoderm, generates into intermediate 
mesoderm, paraxial mesoderm, lateral-plate mesoderm, and chorda-mesoderm; 
in which contributes to muscle, bone, cartilage, connective tissue, adipose tissue, 
circulatory system, lymphatic system, dermis, genitourinary system, serous 
membranes, and the notochord (Tuchmann-Duplessis, David et al. 1971, 
Kimelman and Griffin 2000, Technau and Scholz 2002, Papaioannou 2004, 
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Devine, Wythe et al. 2014, Kyba 2016). The focus of this study will be on the Mesp1 
role in defining mesoderm formation, due to its impact on the formation of 
cardiomyocytes. 
MESP1 is 243 amino acids in length and contains a basic helix loop helix 
domain characterized by analyzing the isolated cDNA and genomic sequence. 
MESP1 mRNA transcripts were observed in the allantois region between the 
extraembryonic, and the epiblast of a 7.5 days post coitum (dpc) mouse embryo 
and validation was visualized using whole-mount in-situ hybridization (Figure 1.2) 
(Saga, Hata et al. 1996).  
The spatial patterning of MESP1 was also compared to alkaline 
phosphatase (ALK), marking the primordial germ cells (PGC).  The first sign of 
MESP1 expression occurred at around 6.5 to 6,75 dpc at the junction of the 
epiblast and extraembryonic ectoderm. Saga and colleagues noted that Mesp1 
expression was quickly down-regulated by 7.5 dpc in the mesodermal cells that 
begin migrating towards the anterior region, but MESP1 transcripts remain at the 
base of the allantois until 8.5 dpc. MESP1 was not located past the embryonic 
node during lateral migration. Transverse section of 6.5 dpc embryos showed that 
MESP1 RNA was expressed in embryonic mesoderm but not in the ectoderm or 
endoderm.  
In 1998, Dr. Saga demonstrated that MESP1 was necessary for proper 
morphogenesis of the heart by generated MESP1-deficient embryos. She found 
that MESP1-null mouse embryos exhibited growth retardation by 7.5 dpc and 
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death by 10.5 dpc due to abnormal head, heart, and somite formation (figure1.3A-
D) (Saga 1998, Saga, Miyagawa-Tomita et al. 1999). MESP1-null mice exhibited 
underdeveloped small head folds, neural fold closure, and embryonic turning was 
delayed (Figure1.4C, D). The null embryos had two symmetrical heart tubes, each 
with the ability to beat suggesting that partial cardio-myogenesis still occurred. 
Transverse sectioning showed two completely separated heart tubes on both sides 
of the midline (Saga 1998).  
 Lineage tracing of MESP1lacZ/+ and MESP1lacZ/- embryos showed strikingly 
different patterning during development. In MESP1lacZ/+ embryos, β-gal stained 
cells showed a lateral migration from the primitive streak, reaching the anterior 
regions. β-gal staining of a cross-section of the heart also showed evidence that 
MESP1 cells contributed to and confined to the myocardium, (Figure1.5D, E) 
However, the MESP1lacZ/- did not undergo lateral migration from the primitive 
streak but remained. (Saga, Miyagawa-Tomita et al. 1999).  
Dr. Saga concluded that the major defect from MESP1-null mice was 
reduced migration of the mesodermal cells. She also concluded that MESP1 is the 
earliest molecular marker for identifying heart precursor cells. MESP1 appears to 
function in other mesodermal lineages, the MESP1-null embryos showed the 
delayed generation of the paraxial mesoderm, but was rescued by MESP2 (Saga 
1998).  
 Dr. Saga and her colleagues showed that MESP1 has a critical role in 
embryogenesis and morphogenesis of the heart field which was supported by 
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extensive lineage tracing which determined the fate of MESP1 marked cells (Saga, 
Hata et al. 1996, Saga, Hata et al. 1997, Saga 1998, Saga, Miyagawa-Tomita et 
al. 1999, Kitajima, Takagi et al. 2000, Saga, Kitajima et al. 2000, Takahashi, 
Hiraoka et al. 2005, Kitajima, Miyagawa‐Tomita et al. 2006, Morimoto, Kiso et al. 
2006), the progression naturally moved towards understanding MESP1’s direct 
role through gain of function investigations. 
In 2008, Dr. Theresa L. Murphy and her colleagues discovered that MESP1 
could induce the Epithelial-Mesenchymal transition (EMT) and restrict the 
cardiovascular fate in differentiating embryonic stem cells. This was the first look 
into what MESP1 could potentially regulate. Dr. Lindsley established that in 
transiently expressing MESP1 cells, levels of PDGFRa and Flk1 markers of 
mesoderm germ layer were increased independently of any wnt-signal induction. 
They also tested T, Cdx2, Eomes, Evx, Hand1, Mixl1, and found that MESP1 was 
the only factor that could induce the mesoderm program without wnt-signalling 
(Lindsley, Gill et al. 2007).  
MESP1 strongly regulates epithelial-mesenchymal transition (EMT) 
measured by the increase of E-cadherin and the decrease of N-cadherin seen by 
immunostaining and by the expression of Snai1. Lindsley et al. (Lindsley, Gill et al. 
2007) demonstrated that MESP1 induced the expression of N-cadherin, the key 
marker for mesenchymal cells and reduced the expression of E-cadherin, the 
molecular marker for epithelial cells by transiently expressing it in differentiation 
embryonic stem cells (ESC). 
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Global microarray analysis on transcripts after 96 hours of induction 
revealed evidence of lineage restriction capability of MESP1. They found that 
MESP1 showed potential to inhibit gene activity associated with the 
neuroectoderm, paraxial mesoderm, and the hematopoietic program. The 
neuroectoderm and paraxial mesoderm markers used in this study were Sox2, 
Pax6, and Pax7. These markers were only expressed when the cells were treated 
with DKK1 but inhibited by MESP1 with or without DKK1 (Figure 1.9A, B). MESP1 
also repressed genes associated with the hematopoietic lineage, but only under 
the conditions of induction of the Wnt signaling pathway, such as Tal1, Gata1, and 
hbb-b1. Also MESP1 can induce cardiac specific genes Myh6, Myh7, Myl2, Myl7, 
Tnnt2, and Nppa, but only with DKK1 (Lindsley, Gill et al. 2007).  
After eight days of post induction, MESP1 sustained the expression of key 
cardiac and smooth muscle transcription factors, Gata4, Gata6, Hand1, Hand2, 
Mef2c, Smyd1 (Bop), Tbx5, Tbx20 Myocd, Foxc1, Foxc2, Tbx1, Zfhx1a, and 
Nkx2.5. In the presence of DKK1, Nkx2.5 appeared to be preferentially expressed, 
which corresponds with their finding for contractility and cTNT expression with 
DKK1 (Lindsley, Gill et al. 2007).  
Therefore, MESP1 can increase the conversion of mouse embryonic stem 
cells into immature smooth muscle cells and functional cardiomyocytes that require 
WNT inhibition by DKK1. Lindsley et al.  (Lindsley, Gill et al. 2007) were able to show 
that two markers, alpha-smooth muscle actin (aSMC) and cardiac troponin (cTNT) 
increased during mouse ES cell programming into cardiomyocytes. Within six 
16 
 
 
days, MESP1 expression increased the presence of aSMC from 4% to 45% in the 
cell population that didn’t display contractile activity. However, with the inhibition 
of WNT by DKK1, expression of MESP1 was was able to induce cTNT and the 
cells showed contractile capability (Lindsley, Gill et al. 2007) 
Since MESP1 expression in-vivo is transient, many of the contractile protein 
genes such as the myosin heavy chain (MHC), which appear several days later, 
are likely the result of indirect activation by downstream factors. The short-term 
effects of MESP1 in mouse-embryonic stem cells at 6 h, 12 h, and 24 h post-Dox 
induction showed that a third of the activated genes were primarily involved in gene 
regulation and signal transduction. Within the first six hours, key factors that 
regulate EMT and cardiovascular lineages were induced, Snai, and Lhx1.  Thus, 
according to Lindsley et al. 2007,  MESP1 is directly inducing the EMT program, 
but  indirectly initiating the core cardiac program.  They also found that Mesp1 
inhibited non-mesodermal lineages, as previously shown by the Saga studies 
(Saga, Hata et al. 1996, Saga, Miyagawa-Tomita et al. 1999, Saga, Kitajima et al. 
2000, Lindsley, Gill et al. 2007). 
 Dr. Antoino Bondue in 2008 within the same year confirmed Dr. Lindsley’s 
findings in MESP1’s ability to activate the core cardiac program, Hand2, 
Myocardin, Nkx2.5, Gata4, Mef2c, Tbx20, or FoxH1. He suggested that due to 
quick response to MESP1, they are direct targets which were not observed by 
Lindsley et al. (Lindsley, Gill et al. 2007). Bondue also observed that MESP1 inhibited 
the appearance of alternative cell fates by repressing early primitive streak 
17 
 
 
specification factors Brachyury and FGF8. Bondue also showed that MESP1 may 
repress endoderm gene activity with the inhibition of Foxa2, Sox17, Gsc, Nodal, 
and Cer1. While Bondue’s temporal study was similar to Lindsley et al. (Lindsley, Gill 
et al. 2007). There are many discrepancies found between these two studies; thus 
begging the question what are the MESP1 direct gene targets? Our answer was 
recently shown in Soibam et al. (Soibam, Benham et al. 2015) and Chapter 2. 
There is a clear difference between the time MESP1 is expressed and when 
the core cardiac program peaks. In EB differentiation MESP1 begins expressing 
as early as day 3 and is quickly down-regulated by day five, while the core cardiac 
markers, Nkx2.5, Hand2, Mef2c, and Troponin, begin expressing at day 6 and 
peaks at day 7-8 (Bondue, Lapouge et al. 2008) and a clear separation In Dr. Lu’s 
investigation of MESP1 marked EYFP+ cells, during early mesendoderm 
activating factors , Eomes, Mixl1, and Mesp1 from the core cardiac program Nkx2-
5, Mef2c, and Tbx5  (Liu, Chen et al. 2016).  
This gap in time would suggest that MESP1 is more likely indirectly 
activating the cardiac program, and should be further investigated. The effects of 
MESP1 is sustained within the population after removal of stimuli suggesting a 
priming role (Lindsley, Gill et al. 2007). The sensitivity of mES cells to MESP1 is 
evident which makes it difficult to determine MESP1's direct targets correctly. Also, 
the artificial expression has the potential of producing false positives. To correctly 
determine MESP1’s valid targets, a global analysis by chromatin 
immunoprecipitation of MESP1 binding sites of endogenous expression should be 
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done. This will give us an accurate assessment of MESP1s role during gastrulation 
and the possible programs that MESP1 activated and repressed (See Chapter 2).  
With that being said, the ability for MESP1 to activate the cardiac program 
autonomously is evident, but the timing between the two events would suggest 
that MESP1 is indirectly activating the cardiac program. If MESP1 is not directly 
activating the cardiac program, its other potential role is altering the chromatin to 
allow other factors to bind. MESP1 potentially could be aiding in chromatin 
remodeling. Understanding MESP1 chromatin remodeling effects will allow for a 
finer tuned approach to cellular reprogramming. However what remains to be 
shown is the mechanism in which MESP1 relays that program after its degradation. 
Two among many possibilities are 1) Is MESP1 priming the binding sites through 
chromatin remodeling similar to a pioneer factor, or 2) Recruiting co-factors that 
will relay the activation signal until target gene is required during differentiation.  In 
my thesis I focused on whether MESP1 is acting as a pioneer factor and altering 
the epigenetic state through chromatin remodeling. 
Epigenetics through chromatin remodeling is the process in which 
nucleosome DNA is made accessible or inaccessible through changes in structure, 
composition, and nucleosome positioning. Two modes of remodeling currently 
have been shown to occur; Covalent histone-modification, and ATP-depending 
remodeling (Teif and Rippe 2009).  
Histone post-translational modification is the addition or removal of various 
elements from histone enzymes like acetylation, methylation, phosphorylation, and 
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ubiquitination. The histone family of protein has five distinct variants H1/H5, H2A, 
H2B, H3, and H4. Each variant except H1/H5 dimerizes and form a complex known 
as a nucleosome. Each histone variant contains an N-terminal ‘tail’ that is not part 
of the tertiary structure and varies in length depending on histone (Strahl and Allis 
2000).  
The tail of each histone has been the focus in determining what 
modifications are present and how it affects chromatin remodeling. The complexity 
of this mechanism is exponential and not yet completely understood. Each histone 
tail contains multiple residues including lysine, arginine, serine, and threonine, 
which can be modified independently, synergistically, and differentially for function. 
Studies into histone post-translational modification addition of methyl, acetyl, and 
phosphoryl groups onto residues mentioned above can mark for either activation 
and or repression, euchromatin, heterochromatin, active promoters, active 
enhancers, and or active transcription (Strahl and Allis 2000).  
Since the discovery of histone modification, histone 3 has been the most 
studied within the complex. Histone3s N-terminal tail that is not part of the globular 
domain is 38 amino acids long, with 16 known sites for modification that are 
essential for remodeling. The histone  H3 tail contains seven lysine residues that 
can be acetylated or methylated, four arginine groups that can be methylated or 
citrullinated, two serine, and two threonine, that can be phosphorylated (Strahl and 
Allis 2000, Bannister and Kouzarides 2011, Venkatesh and Workman 2015). The 
combinatorial complexity is significant to understand how genes are being 
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regulated, but actual genetic loss and gain of function approaches have been 
successful in identifying specific roles for each modification.  
Histone H3 Lysine residue 27 (H3K27), when modified by methylation or 
acetylation, generates epigenetic marks that correlates with active or repressed 
gene activity. Histone Lysine 4 (H3K4), when modified by multi methylations, 
marks active target promoter and enhancer regions. Histone H3 Lysine 36 
(H3K36), when methylated, marks the progression of polymerase II transcription. 
Histone H3 Lysine 9 (H3K9) methylated marks indicate that the target region is 
poised to be converted to be inactive and or heterochromatin in nature.  While 
other histones have been studied the core features of H3 modifications have been 
utilized to determine the state of the chromatin in the global epigenetic analysis; 
thus is important in the analysis of MESP1 expressing cells (Strahl and Allis 2000, 
Bannister and Kouzarides 2011, Venkatesh and Workman 2015, Fiszbein, Giono 
et al. 2016).  For this thesis, I will focus on MESP1’s ability to modulate the 
acetylation and methylation of Histone 3 lysine 27 (H3K27). This lysine, when 
modified, have epigenetic implications for transient, quick, transcriptional 
regulation of target gene. To measure more permanent effects, different 
modification will need to be investigated (Strahl and Allis 2000).  
Each marker is catalyzed by specific core enzymatic complexes and can be 
potentially guided by transcription factors like MESP1 (Smale 2010). For lysine to 
be acetylated, a complex called histone acetyltransferase (HAT) must be recruited 
and bound for acetyl-CoA to be transferred on target lysine. Also, the reverse can 
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occur in which a histone deacetylase (HDAC) can be recruited and remove 
acetylation from target lysine. The same occurs for methylation; to add methyl 
groups to lysine, complex proteins called Histone methyltransferases (HMT) are 
recruited, for demethylation Histone Demethyltransferases (KDM) are recruited 
(Strahl and Allis 2000, Bannister and Kouzarides 2011). However, for lysine 27 
there are specific HATs, HDACs, HMTs, and KDMs that are involved in the addition 
and removal of post-translational modification for the specific function of MESP1 
(Bannister and Kouzarides 2011).  
In 2003, the end of the human genome project, began the revolution of next 
generation sequencing (NGS) and the technologies surrounding it. It dramatically 
changed in the way we approach and theorize the way biology systems function 
(Goodwin, McPherson et al. 2016). Currently, sequencing technologies and 
upstream techniques like ChIP, ChiRP, DNAse, and ATAC allow for the study of 
DNA in respects to chromosomal state (histone modification, DNA methylation, 
etc.), and total RNA in respects to global expression level of micro RNA, Long non-
coding RNA, messenger RNA, etc.  
Since then, the platforms also evolved to be more accessible and affordable 
exponentially increase the generation of NGS data. This explosion of information 
in the past decade fueled the development of new emerging fields of bioinformatics 
and predictive biology. 
Predictive biology or systems biology is the discipline of explaining biologic 
phenomenon at a cellular holistic approach, through net-interactions of all 
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components within it. The dawn of NGS that digitized DNA and RNA sequences 
provided the massive datasets required to successfully predict de novo biological 
outcomes. This allows for the possibility to integrate biological and analytical 
systems to generate datasets to predict dynamic cellular processes. However 
currently bottlenecks in predictive biology is the bridge between the two systems. 
The issues are focused on analyzing and comparing massive datasets and 
integration of different databases (Liu 2005). 
The processing of NGS datasets to be useful for predictive biologist, 
requires an understanding of not just the biological dynamic process but the tools 
in making the dataset useful. In the field of bioinformatics, processing of datasets 
can either be systematic or subjective. Systematic meaning raw data to useful 
datasets, for example raw ChIP data processing into peak location, adjacent gene 
identification using standard software to compile, align, and internal normalization. 
Subjective analysis is more difficult due to its dependence on understanding the 
biological implication of each data set and how they should be compared. This is 
an interdisciplinary hurdle in the development of bioinformatics and predictive 
biology. 
The systematic processing of NGS data of both RNA and DNA require 
different repertoire of software. However, early portions of the established pipeline 
are similar since the data sets would need to be aligned to a reference genome. In 
this study, I used TopHat to align the ChIP-seq and RNA-seq data to the mouse 
reference genome from the National Center for Biotechnology Information (NCBI). 
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For the ChIP-seq analysis of Histone modification and MESP1 binding sites I use 
HOMER software (Heinz, Benner et al. 2010) to annotate each peak with the 
nearest transcription start site, generate bedgraphs to be visualized on the 
University of Santa Cruz Genome Browser, and determine the density of each 
peak. For RNA-seq analysis I use Cufflinks to quantify alignments by Reads Per 
Kilobase of transcript per Million mapped reads (RPKM). Up to this point, it would 
be possible for an individual with little to no biological background to process and 
organize NGS datasets. After this point in the pipeline is highly subjective and 
requires the interdisciplinary coordination that I mentioned earlier and the hurdle 
that is impeding predictive biology. 
The subjective aspect of bioinformatics requires an understanding of both 
the biological experimental process of unknown vs controls and the tools available 
for data processing, or an efficient communication between the experimental 
biologist and the bioinformatictian. This limit is extremely difficult to overcome and 
solutions to increase productivity would require a generation of investigators 
trained enough in both disciplines. Also it would be difficult to expect computational 
sophistication from a generation of biologists and vice-versa (Liu 2005). The 
current solution of increasing productivity is to simplify the systematic process by 
developing web-based user-friendly interfaces of well-established programs like 
tophat (Kim, Pertea et al. 2013), bowtie (Langmead, Trapnell et al. 2009), and 
HOMER (Heinz, Benner et al. 2010) to allow experimental biologist to generate 
useful dataset, circumventing the need for highly skilled bioinformatics or computer 
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scientist. This trend will however meet its limit due to the limitation of current 
available programs.  
My investigation of MESP1 and its epigenetic and transcriptional role will 
highlight both the systematic and subjective process of bioinformatics and the 
potential resourcefulness of predictive biology or systematic biology. With 
Chromatin immunoprecipitation of MESP1, Histone Modification, and RNA-seq 
data, the effects of MESP1 is predicted by cross-comparison of different data-set 
which then are tested experimentally.  
We hypothesize that during expression of MESP1, its primary role may 
include guiding specific enzymatic complexes to designated sites to add and or 
remove specific histone modifications for activation and repression. Understanding 
this role may lead us to understand whether MESP1 is indirectly activating the 
cardiac program. Utilizing chromatin immunoprecipitation, next generation 
sequencing, bioinformatics, predicative biological principals, and or RT-qPCR, we 
will be able to determine if a correlation exists between the regions of MESP1 
binding and Histone3 post-translational modification for activation and repression.  
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2. Chapter 2 Genome‐Wide Identification of MESP1 Targets Demonstrates 
Primary Regulation Over Mesendoderm Gene Activity.  
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2.1. Introduction 
 
MESP1, a basic helix-loop-helix (bHLH) transcription factor, is long known 
for its role in cardiovascular development. Recent evidence indicates that 
MESP1’s role in development is broader than currently recognized. It is the ﬁrst 
sign of the nascent cardiac mesoderm, but it also marks the appearance of 
hematopoietic stem cells, head skeletal mesoderm, and endoderm-derived foregut 
(Kitajima, Takagi et al. 2000, Chan, Shi et al. 2013). Ablation of both MESP1 and 
MESP2 tandem genes led to the absence of the heart, also accompanied by loss 
of most anterior structures (Haraguchi, Kitajima et al. 2001). Identifying the early 
cell lineages regulated by MESP1 is essential for regeneration of the related critical 
tissues (heart, blood, gut, etc.). This requires identiﬁcation of MESP1 direct targets 
in a speciﬁc and unbiased fashion. MESP1 interacts with genomic DNA via ebox 
elements and regulates downstream gene expression (Oginuma, Hirata et al. 
2007). Previously, MESP1 gene targets were identiﬁed by a candidate gene 
approach involving induced overexpression of tagged MESP1 in murine embryonic 
stem cells followed by microarray analysis of the entire mouse embryonic stem cell 
(mESC) population transcriptome. From this data, a few candidate genes were 
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identiﬁed, and MESP1 chromatin immunoprecipitated (ChIP) DNA was analyzed 
to validate them. These studies as a ﬁrst degree approximation of endogenous 
MESP1 signaling deﬁned MESP1 as the most critical factor for cardiovascular 
development (Bondue, Lapouge et al. 2008). Even with the advent of deep 
sequencing technologies, it is still challenging to identify in an unbiased manner 
the transcriptome and chromatome (collective chromosomal state) prompted by 
MESP1-fated cells, especially when MESP1 expression is cell type restricted to a 
group of early progenitor cells and temporally limited to E6–7.5 during 
embryogenesis (Saga, Miyagawa-Tomita et al. 1999, Saga, Kitajima et al. 2000), 
and accordingly transiently expressed in a small percentage (3%–5%) of 
differentiating mES cells (Saga, Kitajima et al. 2000, Wu 2008).  
We have taken steps to circumvent this problem by generating a mouse 
MESP1Cre/1: Rosa26EYFP/+ reporter ESC line (referred to herein as UH3 cells). The 
endogenous MESP1 promoter drives the expression of a knock-in Cre 
recombinase, which in turn activates the expression of EYFP in the Rosa26 locus. 
These cells are hence permanently YFP marked. This enables us to follow MESP1 
progeny over time even though the endogenous MESP1 gene becomes 
repressed. We used this system to study the transcriptome and chromatome of 
cells that were speciﬁed only by endogenous MESP1 signaling. Surprisingly, 
MESP1 primarily directs the appearance of mesendoderm, an early precursor cell, 
which gives rise to mesoderm (specifying cardiac, blood, and bone cells) and 
endoderm (specifying foregut endoderm and the pancreas) structures. 
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2.2. Results 
 
2.2.1. Characterization of an MESP1 Lineage-Tracking ESC Line 
 
An MESP1-lineage reporter mouse ES cell line (UH3) was isolated from 
E3.5 blastocysts resulted from an MESP1Cre/+ and Rosa26EYFP/EYFP crossing 
(Figure 2.1A). The cells bore an MESP1Cre/+; Rosa26EYFP/+ genotype showed 
characteristic mES cell morphology (Appendix B Figure S1A) and had a normal 
male karyotype (Appendix B Figure S1B). To characterize the UH3 cell line and 
confirm that they undergo differentiation similar to wildtype mES cell lines such as 
AB2.2, we aggregated the cells in hanging drops, harvested the embryoid bodies 
over time, and examined the gene expression using quantitative real-time PCR 
(qRT-PCR). As expected, we observed a transient induction of MESP1 expression 
in UH3 cells similar to AB2.2 control (Appendix B Figure S2; Figure 2.1B, C). 
MESP1 transcript expression coincided with the upregulation of Gata4 and Tbx5 
genes, while Nkx2.5 and Mef2c expression increased about 1–2 days after MESP1 
expression had diminished, marking the induction of the cardiac progenitor cell 
program (Appendix B Figure S2). Cell surface markers appeared sequentially 
among which Cxcr4, a marker for mesendoderm, appeared concurrently with 
mesoderm markers Pdgfra and Flk1 (Nelson, Faustino et al. 2008) (Appendix B 
Figure S2). Increased expression of Sirpa and Alcam, markers of blood and 
cardiac myocytes, respectively (Dubois, Craft et al. 2011), followed several days 
later indicating that the UH3 cell line follows a multi-mesoderm lineage 
differentiation program (Nelson, Faustino et al. 2008, David, Schwarz et al. 2013). 
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We further confirmed that UH3 cells undergo cardiac differentiation by well-
organized sarcomeres in YFP+ UH3 cells eight days post-hanging drop (Appendix 
B Figure S1C). Finally, UH3 cells in culture exhibited rhythmic beating (Appendix 
B Figure S1D). 
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Figure 2.1. Methodology for MESP1-lineage tracing. (A): The strategy in generating mouse 
MESP1Cre/+;Rosa26EYFP/+ reporter embryonic stem cell (ESC) line. (B): The expression of 
MESP1 mRNA during ESC differentiation, as assayed by realtime RT-PCR. (C): The 
expression of MESP1 during ESC differentiation, as determined by western blot. (D): 
Percentage of fluorescence-activated cell sorting-sorted YFP+ MESP1 lineage cells 
during the course of ESC differentiation. (E): Schematic details of the methodology for 
MESP1-lineage tracing and whole genome analyses. Abbreviations: EB, * * *; ESC, 
embryonic stem cell; FACS, fluorescence-activated cell sorting; FSC, forward scatter. I 
contributed with culturing and FACsorting EB differentiating cells.  
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2.2.2 Transcriptome of MESP-Marked Progenitor Cells Signified Contribution to 
the Mesendoderm Lineage  
 
Our strategy, as illustrated by the schematic diagram, was to follow the 
transcriptome and chromatome of MESP1-fated cells (Figure 2.1E). Briefly, UH3 
cells were differentiated by hanging drops, then staged YFP+ cells were isolated 
to follow MESP1 progeny. Percentages of MESP1-YFP+ cells at each stage are 
shown in Figure 1D. EYFP signal started to appear as early as day three (Figure 
2.1B), while Mesp1 transcripts peaked at day 4 (Figure 2.1C). MESP1 protein was 
enriched at day five, as shown by western blot (Figure 2.1C). To identify the 
transcriptome, RNA was isolated from equal numbers of undifferentiated mES cells 
and sorted MESP1-YFP+ cells at days 5, 6, 7, and 8 for next-generation 
sequencing analysis (Done by Benham) (Figure 2.2A). Using mouse refseq genes 
as the reference annotation (mm9 version), gene expression profiles (Appendix 2 
Table S1) were obtained from RNA-Seq data using tophat (Kim, Pertea et al. 
2013), and cufflinks (Done by Soibam and Kim) (Trapnell, Williams et al. 2010).  
To understand the temporal expression patterns of genes in MESP1-
marked progenitor cells, we first identified genes that were upregulated (p<0.05) 
at day five MESP1-YFP+ cells as compared to mES cells using DESeq (Anders, 
Anders et al. 2010) and performed gene ontology (GO) analyses for this gene set 
(Done by Soibam and Kim) (Appendix B Table S2, Figure 2B). The highest 
significance was representatives of mesoderm GO terms such as heart 
development (89 gene count with p-value of 3.1x10-27), skeletal system 
development (91 gene count, p-value of 5.09x10-20), and vasculature development 
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(80 gene count with p-value of 9.41x10-14), and followed by neuron development 
(58 gene count with p-value of 4.20x10-10). Currently, there is not a well-defined 
mesendoderm GO term, but many endoderm GO terms such as respiratory system 
development (36 gene count, a p-value of 3.33x10-7), pancreas development (14 
gene count, a p-value of 1.57x10-4) were significantly enriched. Interestingly, 
upregulated genes at day 6, 7, and 8 MESP1-YFP+ cells, also showed the highest 
enrichment both for mesoderm and endoderm-associated GO terms (Figure 2.2B). 
We also noticed a general increase in the number of upregulated genes pertaining 
to developmental GO terms (Appendix B Table S2) with the progression of 
differentiation. For instance, the number of heart development associated genes 
at day 5, 6, 7, and 8 were 89, 85, 110, and 115, respectively. The highly enriched 
endoderm representative term— respiratory tube development had 32, 34, 43, and 
44 upregulated genes in day 5, 6, 7, and 8 YFP+ cells.  
To further validate the enriched transcriptome in the YFP+ cells, we asked 
whether H3K4me3 modification patterns are correlated with the transcriptome 
quantification. High-quality H3K4me3 ChIP-Seq was performed for ES and day 
five YFP+ cells (Done by Kim) (Appendix B Figure S3A, S3B). Next, broad peaks 
were identified using MACS2 (https://github.com/taoliu/ MACS/, an updated 
version of study in ref. (Zhang, Liu et al. 2008)) with an false discovery rate (FDR) 
<0.01. H3K4me3 peaks were preferentially located near transcription start sites of 
genes (Done by Soibam and Kim) (Appendix B Figure S3C, S3D, and Table S3). 
Genes with H3K4me3 peaks in their promoters had significantly higher expression 
levels (more than a fivefold mean expression) than those without H3K4me3 peaks 
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at their promoters (Figure 2.2C). This correlation between the H3K4me3 ChIP 
peaks and RNA-Seq expression profiles validates the set of actively transcribed 
genes from our RNA-Seq data, agreeing with observed association of active 
promoters with H3K4me3 modifications. As representative genes, MESP1 itself 
was transitorily expressed on day five (Figure 2.2D), agreeing with RT-PCR 
findings (Figure 2.1C). Foxa2, a classic marker of endoderm, was expressed at 
higher levels in YFP+ marked cells at day six, after the fall of Mesp1 mRNA (Figure 
2.2D). Nkx2-5, a classic cardiac marker, was enriched later in YFP+ cell at the final 
time points (Figure 2.2D), while expression of Eomes, a mesendoderm marker, 
correlated to that of MESP1 (Figure 2.2D). Hierarchical clustering of genes 
associated with heart development, mesoderm development, and endoderm 
development GO terms revealed subsets of genes that were specific for 
differentiation stages (Figure 2.2E; Appendix B Figure S4). Next, to determine 
whether MESP1 YFP+ cells and YFP+ cells showed different expression 
signatures for mesendoderm lineage, we identified differentially expressed genes 
using DESeq (Done by Soibam and Kim) (p<0.05). Genes upregulated in YFP+ 
cells were consistently enriched in heart development related terms at day 5, 6, 7, 
and 8 (Figure 2.2F; Appendix B Table S4). Differentially expressed genes (at day 
5, 6, 7, and 8) between YFP+ and YFP- cells showed stronger enrichment of 
mesoderm and endoderm lineage terms in YFP+ cells (Figure 2.2F; Appendix B 
Table S4). Thus, our data indicate that the MESP1-marked cells express a unique 
molecular signature, and are destined to become cardiac progenitors and other 
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subsequent mesendoderm-derived lineages after the transient appearance of 
MESP1.
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Figure 2.2. Transcriptome of MESP-marked progenitor cells signified contribution to the 
mesendoderm lineage. (A): Transcriptome profiling of MESP1 YFP+ cells using RNA-Seq. 
(B): Enriched gene ontology (GO) developmental ontology terms associated with 
upregulated genes. Comparisons were made at multiple time points (days 5, 6, 7, and 8) 
between YFP+ and undifferentiated embryonic stem cells. (C): Correlation of H3K4me3 
signal with mRNA expression levels. The H3K4me3 signal for a gene was computed as the 
normalized read count in a 2-kb interval centered at the transcription start site of the gene. 
(D): Dynamic expression profiles of Mesp1, Foxa2, Nkx2-5, and Eomes in the form of 
mapped RNA-Seq reads and H3K4me3 ChIP-Seq reads to mouse genome. The scales 
between the RNA-Seq alignment profiles across different days were adjusted for visual 
comparison. Similar adjustment was made between embryonic stem cell and day five for 
H3K4me3 profiles. (E): Hierarchical clustering of genes associated with GO terms—
mesoderm development, endoderm development, and heart development. The robust z-
score for each gene across the samples is reported. The cosine similarity was used as the 
distance metric. Detailed heat map at individual gene level is accessible in Appendix B
Figure S4. (F): GO terms for differentially expressed genes between YFP+ and YFP- cells 
at days 5, 6, 7, and 8. Abbreviation: mESC, mouse embryonic stem cell. (I contributed with 
ChIP-seq library generation and Immunoprecipitation of target protein) 
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2.2.3 Identification of MESP1 Genomic Binding Sites by ChIP-Sequencing 
 
To identify MESP1-binding sites, we performed MESP1-ChIP on day four 
differentiating ESCs and used next generation sequencing technology to obtain 
the enriched DNA fragments in the form of raw reads of 40 nt from a single end 
(Done by Kim, Weng, and Yang). These raw reads were aligned to the mouse 
genome allowing a maximum of two mismatches per read (Done by Soibam and 
Kim). The alignment profile of MESP1 ChIP-Seq data passed data quality criteria 
by ENCODE (Landt, Marinov et al. 2012) (Figure 2.3A, 19 million uniquely mapped 
reads, relative strand correlation (RSC) 51.27, Qtag51, normalized strand 
correlation [NSC]51.18). We also generated an appropriate input DNA from the 
same cells at day four (Done by Kim, Weng, and Yang). We applied widely used 
MACS2 to the MESP1 ChIP-Seq data and the control background to obtain 43,346 
binding sites (peaks) (Appendix B Table S5) with a stringent p-value cutoff of 10-8 
(Done by Soibam and Kim).  
Genomic annotation of the peaks revealed that about 25% of MESP1 peaks 
resided in promoter (61 kb of nearest transcription start site [TSS]), 26% within the 
introns, 28% in Exons, and 19% in intergenic regions (Figure 2.3B); further 
analysis of the positional distribution of peaks from the nearest transcription start 
site (TSS) showed that majority of the promoter peaks (6,448 out of 9,444) were 
located within 500 bp from the nearest TSS (Figure 2.3B). Interestingly, 50% of 
peaks were located at intergenic or intragenic distal enhancers (>10 kb from TSS). 
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2.2.4 MESP1-Bound Sequence Characteristics 
 
MESP1 directly binds gene regulatory regions containing basic helix-loop-
helix binding sites or eboxes (Haraguchi, Kitajima et al. 2001, Bondue, Lapouge et 
al. 2008). To determine the enriched sequence motifs, we first examined ebox 
sequences in MESP-bound peaks. A total of 78% peaks contained at least one 
canonical ebox (CANNTG). Using a logistic regression model for ebox occupancy 
and adjusted GC content in the peaks (Appendix A Materials and Methods), we 
found that 12 of 16 variants of ebox sequences had significant enrichment (p<1x10-
06) in MESP1 bound peaks compared with the random background set (Done by 
Soibam and Kim) (Appendix B Figure S5). The six highest scoring variants with at 
least 10% occupancy are shown in Figure 2.3D, and all these six variants passed 
ENCODE’s standard of motif occupancy of at least 10% of peaks. Strongest 
preference was observed for ebox variant “GC” followed by “CG” (Figure 2.3D). 
Overall, the variant CASSTG (S stands for C or G) was preferred over the rest of 
the other variants; 26%, 16%, 22%, and 22% of peaks have the CAGCTG, 
CACGTG, CACGTC, and CACCTG motif, respectively. The distribution of these 
four variants on the MESP1 peaks was also clustered at the vicinity of the peak 
summits (Figure 2.3E). To supplement the ebox searches, we used HOMER 
(Heinz, Benner et al. 2010) and FIMO (Grant, Bailey et al. 2011) to scan for the 
presence of known JASPAR (Mathelier, Zhao et al. 2014) binding motifs in MESP1 
bound regions. Interestingly, the top enriched motifs by both HOMER and FIMO 
comprised of different versions of ebox motifs (MYCN, MYOD1, TCF3, TCF12, 
MYOG, AP4, PFTA, MAX) (Appendix B Figure S6); the top two variants being “CG” 
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and “GC” (Figure 2.3F). This analysis agrees with our earlier observation that 
CAGCTG and CACGTG are the top two MESP1 preferred binding motifs. Analysis 
using HOMER revealed difference in the immediate flanking bases for “CG” and 
“GC” variant (Figure 2.3F). Similar to the previous study on MYOD (Cao, Yao et 
al. 2009), MESP1 binding is dependent on flanking and internal nucleotides of 
CANNTG ebox.  
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Figure 2.3. Genome-wide characterization of MESP1 binding sites. (A): Quality control 
of MESP1 ChIP-Seq data using the ENCODE standard. Cross-correlation curve peaks 
approximately at the fragment length 120 bp and not at the read length (40 bp). Other 
ChIP-Seq quality metrics such as normalized strand coefficient (NSC), relative strand 
correlation (RSC) were above the standard suggested by ENCODE (according to 
ENCODE, minimum NSC, and RSC values should be 1.05 and 0.8, respectively). (B): 
MESP1 peaks annotated as intergenic, promoter (within61 kb of transcription start site), 
Exon, intron, and TTS. (C): Histogram of number of MESP1 peaks with respect to the 
nearest transcription start site. MESP1 peaks were found in the promoter as well as in 
distal intragenic or intergenic regions. (D): The top four variants of ebox motifs enriched 
in MESP1 peaks compared with background (p<10–16). The statistical significant 
difference was computed using a logistic regression of E-box occupancy and adjusted 
GC content in the MESP1 peaks (Appendix A Materials and Methods) compared with 
background sequences. The number of MESP1 peaks and the background sequences 
containing the ebox variant along with motif enrichment scores are also indicated. (E): 
Distribution of top four variants of eboxes along MESP1 peaks. The eboxes are clustered 
around the peak summits. (F): Top Enriched motifs in MESP1 peaks obtained using two 
different methods (HOMER and FIMO). Both HOMER and FIMO predicted the same 
variants (“GC” and “CG”) as the two top motifs in MESP1 peaks, which matches the result 
in (D). Abbreviations: NSC, normalized strand correlation; RSC, relative strand 
correlation; TSS, transcription start site. (I contributed in analyzing NGS ChIP-seq data) 
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2.2.5 MESP1 Targets Genes Involved in Mesendoderm Formation 
 
To identify gene targets associated with ChIP-Seq peaks, we compiled a 
list of 14,006 “potential MESP1 targets” by assigning each peak (43,346 peaks) to 
the gene whose TSS was closest. We further refined the list by incorporating the 
MESP1-YFP+ cells transcriptome. We retained 6,470 targets which exhibited 
differential expression (RNA-Seq, p<0.05) at day five YFP+ cells compared with 
ESCs (Done by Soibam and Kim) (Figure 2.4A). 3,201 and 3,269 were MESP1 
activated and repressed targets (Appendix B Table S5; Figure 2.4A), depending 
on either an increase or decrease in their expression at day five YFP+ cells 
compared with ESCs. Promoters at MESP1 activated targets showed a significant 
amount of increase in H3K4me3 modification compared with the repressed targets 
(Appendix B Figure S7).  
To determine the biological functions of MESP1 direct targets, we 
performed separate GO analysis for MESP1 activating and repressing targets 
using mouse genome as the background (Done by Soibam and Kim). GO terms 
pertaining to both mesoderm development (p=1.89x10-9) and endoderm 
development (p=3.98x10-5), a variety of signaling pathways (Shh, TGF, BMP, Wnt, 
Notch, and FGF), and next-tier GO terms denoting mesendoderm-derived 
organogenesis were significantly enriched in the MESP1 activated targets (Table 
2.1; Figure 2.4B). Thus, MESP1 activation targets are strongly enriched for 
mesoderm and endoderm developmental GO terms, indicating that MESP1 
directly regulates developmental pathways pertaining to mesendoderm other than 
strictly a cardiac lineage. However, the MESP1 repressing targets were not 
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enriched in mesendoderm related terms, but in GO terms pertaining to broad 
biological processes such as cell cycle processes (Appendix B Table S5).  
To better understand the dynamic expression patterns of MESP1 activated 
targets, we next performed unsupervised hierarchical clustering of their expression 
profiles (mES cells and YFP+ cells from days 5, 6, 7, and 8) (Done by Soibam and 
Kim) (Figure 2.4C). Our analysis revealed nine groups of targets showing unique 
temporal expression patterns (Figure 2.4C). Cluster assignment for the targets is 
provided in Appendix B Table. S5. To further understand the functions associated 
with these clusters of targets, we performed GO analysis for each cluster. 
Interestingly, targets whose expression transiently peak at day five (cluster 9 in 
Figure 4C) showed the highest enrichment in gastrulation, pattern specification, 
and embryonic morphogenesis (Figure 2.4D). Mesendoderm-derived 
organogenesis was associated with MESP1 targets whose expression became 
most prominent at day six or beyond (Figure 2.4D). Such patterns indicate that 
MESP1 target genes form a coordinated gene network that drives mesendoderm 
formation and subsequently lineage specifications.  
We also filtered the “potential MESP1 targets” through differentially 
expressed genes between day five MESP1 YFP+ and YFP- cells (Done by Soibam 
and Kim) (Figure 2.4A, right branch). This comparison yielded 475 activated and 
796 repressed targets. This set of MESP1 activated targets also showed strong 
enrichment for mesoderm (p=1.13x10-7) and endoderm development (p=0.0046), 
while the repressed targets showed no enrichment for these terms (Figure 2.4B; 
Appendix B Table S5). GO terms for ectoderm development showed enrichment 
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in repressed targets (Figure 2.4B) but not in activated targets. This indicates that 
MESP1 activated targets contribute to mesoderm and endoderm programs. Other 
GO terms associated with mesendoderm-derived organogenesis also showed 
enrichment among MESP1 activated targets when referenced to day five YFP- 
cells (Figure 2.4B). The 797 MESP1 repressed targets showed small enrichment 
for endoderm-associated terms pertaining to lung development (p=0.0016), 
pancreas development (p=0.0153). But, these GO terms also showed enrichment 
in MESP1 activated targets. Terms related to gut development were absent in the 
repressed targets, which indicates that MESP1 YFP+ cells contribute more to gut 
lineages than the YFP- population. Using two different reference systems (mES 
cells and day five YFP- cells), we identified two sets of MESP1 directly activated 
targets, and both sets showed strong enrichment of both mesoderm and endoderm 
GO terms. Thus, MESP1 directly regulates developmental pathways pertaining to 
mesendoderm other than strictly a cardiac lineage.  
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Figure 2.4. Functional assessment of MESP1 targets. (A): Stepwise filtering in identifying high-
confidence MESP1 activation targets. First, MESP1 peaks were identified from 19 million 
unique mapped reads from ChIP-Seq. Each peak was assigned to a gene with its transcription 
start site nearest to the peak. The genes whch showed differential expression (p<0.05) 
between embryonic stem cell and day five YFP+ cells were retained as MESP1 direct targets, 
and we obtained 3,200 MESP1 activated, and 3,268 repressed targets, respectively. In a 
second approach, we compared day five YFP+ cells to YFP+ cells and obtained 476 activated 
and 797 repressed targets. (B): Gene ontology (GO) analysis of MESP1 activated and 
repressed targets. The color scale in the heat map is shown as -log10 p value. (C): Clustering 
of MESP1 activation targets on the basis of their temporal expression pattern. Hierarchical 
clustering was performed using the fragments per kilobase of exon per million fragments 
mapped (fpkm) values at days 0, 5, 6, 7, and 8 YFP+ cells. Nine maximally homogeneous 
clusters were obtained; example genes for each cluster are also indicated. Cluster assignment 
for the MESP1 activated targets can be assessed in Appendix B Table S5. (D): Individual GO 
analysis of MESP1 activated genes belonging to the nine clusters. The color scale is indicated 
in -log10 p value. Abbreviation: mESC, mouse embryonic stem cell. 
43 
 
 
 
 
 
 
 
 
 
 
 
44 
 
 
Since “mesendoderm development” is only partially completed, there is not 
a proper GO term (Ashburner, Ball et al. 2000), to test if MESP1 targets key 
mesendoderm regulators. We investigated individual genes that are directly 
involved in mesendoderm development. Mesendoderm markers such as Gata4, 
Eomes, Wnt5a, Wnt5b, Mixl1, T, Gsc, and Wnt3 were among MESP1 activated 
targets (Figure 2.5A). We found that MESP1 may regulate itself, perhaps through 
a binding site located about 28 kb from the TSS (Figure 2.6E). Hematopoietic 
transcription factors such as Tal1, Meis1, and Lmo2 were also direct MESP1 
activated gene targets, while other key regulatory blood factors, Gata1, Hbby, and 
EBf1 and cardiac progenitor markers, Nkx2-5, Mef2c, and Tnnt2 were not 
(Appendix B Table S5; Figure 2.5C). In YFP+ cells, MESP1’s temporal expression 
pattern correlated well with the appearance of mesendoderm gene expression 
(such as Gata4, Mixl1, Wnt5b, Wnt3, and T) while significantly differing from that 
of key cardiac and blood genes (Figure 2.5C). Thus, MESP1 indirectly regulates 
the cardiac or hematopoietic differentiation programs in a discrete MESP1 
enriched population (Bondue and Blanpain 2010). We also examined the 
expression of these key mesendoderm markers in the YFP- population. Most of 
the mesendoderm markers except T showed significantly higher expression at day 
five in YFP+ cells than YFP- cells (Figure 2.5A). MESP1 activated targets, which 
are involved in cardiac and hematopoietic programs, are higher in YFP+ cells 
compared with YFP- cells at later stages of differentiation (after day five), indicating 
an indirect regulation of these programs by MESP1 (Figure 2.5A).  
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Previous studies using MESP1 overexpression followed by ChIP-PCR 
reported that MESP1 bound to conserved E-box sites at regions close to the TSS 
of Foxa2 (5 kb), Sox17 (4 kb), Gsc (4.5 kb), and T (1.5 kb), lead to rapid down-
regulation of these genes (Bondue, Lapouge et al. 2008, Bondue and Blanpain 
2010). In our unbiased approach, endoderm markers Foxa2 and Sox17 were 
MESP1 activated targets (Figure 5A). It is possible that upon forced induction, 
MESP1 binds to regions indicated by the previous study (Saga, Kitajima et al. 
2000) close to TSS and down-regulates the important endoderm markers, likely 
through an inhibitory complex. In YFP+ cells, endoderm genes Foxa2, Cer1, and 
Sox17 began to appear at day five and peak at day six, while MESP1 levels fell 
and disappeared. These data suggest that a subset of MESP1 YFP+ cells, at a 
later stage showing definitive endoderm (DE) lineage characteristics did not 
depend on continuous MESP1 gene expression. Sox17, Foxa2, and Cer1 were 
expressed at higher levels in YFP- cells at days five, six, and eight (only Foxa2) 
indicating that YFP- cells primarily contribute to the endoderm lineage. To prove 
the concept, we costained YFP+ cells with T, Foxa2, or Sox17 in day 5 
differentiated cells (Figure 2.5B). Both T and Foxa2 were highly prevalent, 
agreeing with efficient mesendoderm formation. YFP signals were located in the 
cytosol and were frequently detected in T or Foxa2 positive cells. Sox17 signals 
were more restricted in a small number of clustered cells, agreeing with limited 
endoderm differentiation. Co-staining of Sox17 and YFP was also evident. 
Although T, Foxa2, and Sox17 were more prevalent in YFP- cells, our data suggest 
that MESP1 is associated with at least a population of mesendoderm cells which 
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contribute to endoderm lineages, but only after the reduction of MESP1 gene 
activity.  
We further explored GO terms associated with MESP1 activated targets 
which were differentially expressed between YFP+ and YFP- cells at different time 
points during differentiation. For this, we compiled two lists of MESP1-activated 
targets. The first group consists of targets which were strictly expressed at higher 
levels in YFP+ cells during differentiation, while the second group was strictly 
expressed at the higher expression in YFP- cells during differentiation. The first 
group showed more enrichment in mesoderm and endoderm-derived 
organogenesis, the majority being in the endoderm. (Appendix B Figure S8). 
However, some of the endoderm terms such as respiratory and lung development 
were also enriched in the second group. This indicates that some of the genes, 
which are activated post-MESP1 expression in the YFP+ cells, are also expressed 
in the YFP- population and may contribute to endoderm lineages. Such genes are 
most likely regulated by other factors, independent of MESP1, in the YFP- 
population. 
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Figure 2.5. MESP1 directly regulates mesendoderm genes. (A): mRNA expression levels, 
differential expression between YFP+ and YFP- cells, and ChIP-Seq peak scores of key 
mesendoderm, endoderm, cardiac, and blood genes. For each lineage-specific group of 
genes, there are three heat maps placed in three subpanels. The first heat map represents 
expression profiles of the key markers in mouse embryonic stem cell (mES), YFP+ and YFP-
cells at different time points. The middle heat map indicates if the gene was differentially 
expressed between YFP+ versus mESCs/YFP cells at different time points. In this heat map, 
“red,” “blue,” and “white” colors indicate up-regulation in YFP+, down regulation in YFP-, and 
not differentially expressed, respectively. The third map represents the peak score from the 
MESP1 ChIP-Seq associated with the gene. The color scale of peak score is shown as log2 
of read-count. In case of multiple peaks assigned to the same gene, the one with the highest 
score was used. The peak scores for non-MESP1 activated targets are shown as blank. (B): 
Co-immunostaining analysis of MESP1-lineage and T, Foxa2, and Sox17. The arrows point 
to cells that show nuclear T, Foxa2, or Sox17 staining and cytosol YFP staining. 
Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; mESC, mouse embryonic stem cell; 
GFP, green fluorescent protein. 
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2.2.6. MESP1 May Recruit H3K27ac Epigenetic Modification to Distal Regulatory 
Regions 
 
To assess if MESP1 binding sites might modify local chromatin structure, 
we compared MESP1 ChIP-Seq data to H3K27ac ChIP-Seq data from enriched 
mesoderm cells (Wamstad, Alexander et al. 2012), and also to H3K4me3 tracks 
generated in this study (Done by Soibam and Kim). In the enriched 43,346 MESP1 
binding sites, the amount of H3K27ac showed a strong correlation (Pearson 
correlation coefficient 50.91, Figure 2.6A) with a MESP1-binding signal. A similar 
correlation was also observed (Pearson correlation coefficient 50.84, Figure 2.6B) 
in intergenic or intragenic distal peaks (>10 kb from TSS).To determine if H3K27ac 
at MESP1 bound regions are MESP1-binding dependent, we compared the 
amount of H3K27ac at MESP1-bound regions in mesoderm cells to that in ESCs 
(Done by Soibam and Kim). An increase in the amount of H3K27ac was observed 
between ESCs and mesoderm cells at MESP1-bound peaks and also only at distal 
enhancers (Appendix B Figure S9; Figure 2.6C, 6D). Core mesendoderm genes, 
Gata4, Wnt3, Gsc, Gata4, Gata6, and Mixl1, displayed enhanced H3K27ac histone 
modification in MESP1-binding regions and heightened H3K4me3 epigenetic 
modifications at their promoters in comparison with virtually nil levels in ESCs 
(Figure 2.6). MESP1 DNA binding displayed a de novo appearance of H3K27ac 
modification at endogenous binding regions of MESP1, but H3K4me3 levels were 
already present in replicating mES cells (Figure 2.6E), likely due to activation by 
Oct4 and Lef1/b-catenin (Li, Yu et al. 2013). We propose that MESP1 target sites 
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that incorporate the genetic signature of increased H3K27ac and H3K4me3 are 
likely participants in the acquisition of more differentiated states and constitute an 
essential mechanism for the transition of pluripotency to mesendoderm. 
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Figure 2.6. MESP1-binding correlates globally with H3K27ac epigenetic modification. (A): 
H3K27ac signal correlates globally with MESP1 ChIP signals. At all the MESP1 peak 
locations, the H3K27ac ChIP signal correlated with MESP1 ChIP signal with a Pearson 
correlation of 0.91. (B): H3K27ac signal correlates with MESP1 ChIP Signal at MESP1 
enhancer peaks. At all the MESP1 peak enhancer locations, the H3K27ac ChIP signal in 
mesoderm cells correlated with MESP1 ChIP signal with a Pearson correlation of 0.84. (C): 
Increase in H3K27ac signal at MESP1 peak regions from mouse embryonic stem cell 
(mESC) to mesoderm cells. (D): Increase in H3K27ac signal at MESP1 peak enhancer 
regions from mES cells to mesoderm cells. (E–J): Alignment profiles of ChIP-Seq reads at 
loci of selected MESP1 mesendoderm targets. The alignment profiles represent the read 
depth at resolution of 1 nucleotide. Profiles are shown for MESP1, Gsc, Gata4, Gata6, 
Wnt3, and Eomes. The identified MESP1 binding regions which are enriched compared 
with background ChIP-Seq data with p<10-8 are shaded in gray. The scales for H3K27ac 
plots between mES cells and day five were adjusted for visual comparison between the 
two conditions. Similar adjustment was done for H3K4me3 plots between mES cells and 
day five. Abbreviation: mES, mouse embryonic stem cell. (I contributed in analyzing NGS 
ChIP-seq data) 
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2.3. Discussion 
 
Mesendoderm, an ancient germ layer from worms to frogs, gives rise to 
both endoderm organs such as liver, foregut, and pancreas and mesoderm organs 
such as heart, blood, and bone (Rodaway and Patient 2001). Mesendoderm is 
implicated as the major source of cardiac mesoderm and anterior endoderm in 
mammals, a part of which can eventually differentiate into hepatocytes and 
pancreatic cells (Wells and Melton 1999). From C.elegans up to Xenopus, NODAL, 
WNT5A/B, PITX2, GSC, MIXL1, EOMES, and GATA4/6 have been shown to 
participate in mesendoderm induction (Wells and Melton 1999, van den Ameele, 
Tiberi et al. 2012). The origin of mammalian mesendoderm has not been as well 
studied, but mesoderm and endoderm cell–cell interactions are especially 
important. Our model depicts how MESP1 directs a mesendoderm bi-potential 
developmental pathway and serves as a novel paradigm shift for MESP’s role in 
the cardiopoiesis program. We profiled the transcriptome of a pure population of 
MESP1-marked cells along with determining the chromatome of endogenous 
MESP1-bound DNA targets. Surprisingly, MESP1 primarily directs the appearance 
of mesendoderm instead of the cardiac program per se. Critical mesendoderm 
modulators including Mixl1, Pitx2, Gata4, Gata6, Wnt5a, Wnt5b, Sox17, and Foxa2 
were enriched in MESP1-YFP+ cells before the appearance of cardiac progenitors 
and myocytes.  
Previously, we demonstrated that an endoderm-associated Sry-box 
transcription factor, SOX17, was essential for cardiac specification in 
differentiating mES cells acting at least in part via cell-non-autonomous 
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mechanisms (Liu, Asakura et al. 2007). Recently, we showed in unbiased genome-
wide testing, SOX17 expression in ESCs was a prerequisite for the induction of 
highly diverse cardiogenic transcription factors and cardiac structural genes (Liu, 
Kaneda et al. 2014). HHEX and CER1 are indispensable components of the 
SOX17 pathway for cardiopoiesis in mES cells, acting at a stage downstream from 
MESP1/2. Our demonstration that Sox17, Foxa2, and Cer1 are MESP1 targets 
and their transcripts become enriched in MESP1-YFP+ cells supports the idea that 
mesendoderm cells initiate a potent auto-regulatory program to direct the earliest 
cardiac and endoderm progenitors.  
We used a stepwise filtration to identify “MESP1-activation targets”. MESP1 
ChIP-Seq alone, however, resulted in a total of 43,346 MESP1 binding sites 
among which most resided both on regions distal as well as close to TSS.  The 
peaks were significant with a stringent p-value of 10-8 compared with the 
background, our ChIP-Seq data passed high-quality criteria recommended by 
ENCODE, and correlated with H3K27 acetylation indicating that the peaks are 
specific. Interestingly, ChIP with another lineage-specifying bHLH factor, MyoD, in 
myoblasts and myotubes yielded a lot of reads in distal enhancer regions, which 
also showed increased H4 acetylation (Cao, Yao et al. 2009). Why these 
regulatory regions harbor activating histone modification without net downstream 
activation is intriguing. Perhaps the bHLH-recruited histone acetylation leads the 
genes to a “poised” status, ready for expression in the next stage of cellular 
differentiation, which is an interesting direction to pursue in future studies.  
53 
 
 
Forced expression studies are held with some degree of skepticism when 
their activity is extrapolated to the behavior of the endogenous factor. Recently, 
Tapscott and colleagues provided a litany of cogent reasons why the legitimacy of 
forced expression studies may be questionable, such as nonphysiological 
conditions and non- specific DNA binding; even though as a point of fact they did 
not detect significant differences between their unbiased MyoD ChIP assays and 
overexpression data (Yao, Fong et al. 2013). We compiled a list of DNA regions 
which were previously tested for MESP1 enrichment using ChIP-PCR by forced 
expression (Bondue, Lapouge et al. 2008). About 25% of the MESP1 enriched 
regions identified were detected by our MESP1 ChIP-Seq. We also compared the 
genome-wide binding of endogenous MESP1 against the microarray analysis 
following MESP1-overexpression (Table 1 of the published work by the Blanpain 
group) (Bondue, Tännler et al. 2011). 155 (145 activated and 10 repressed targets 
in our data) out of 216 potential MESP1 DNA-binding targets were confirmed 
(Appendix B Table S6). MESP1 was claimed to promote the expression of cardiac 
structural genes, such as Myh7 (b-MHC), Myh6 (a-MHC), Myl1 (MLC1f), Myl2 
(MLC2v), and Tnnt2 (cTnT), but none of these contractile proteins, which appear 
almost 2–3 days after the transient induction of MESP1, were identified to be direct 
targets. We also found concordance between the published findings by Lindsley 
et al, 2007. and ours in which their transient MESP1 expression in mES cells 
markedly increased the frequency of PDGFRa1 and FLK11 cells (Lindsley, Gill et 
al. 2007). We noted that Pdgfra and Flk1 are MESP1 targets. Also, MESP1 
robustly induces transcription factors that regulate EMT, such as Snai1 and Twist 
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(Carver, Jiang et al. 2001, Thiery and Sleeman 2006) which were also confirmed 
by our study, as MESP1 gene targets (Appendix B Table S5). Furthermore, 
MESP1 failed to induce paraxial mesoderm genes, such as Meox1, Tcf15, Tbx6, 
or Pax1 (Sakurai, Era et al. 2006) or skeletal, myogenic transcription factors Myod, 
Myogenin, or Myf5. Besides DE markers such as Foxa2, Cer1, and Sox17, MESP1 
also binds to DNA regions associated with visceral endoderm (VE) markers such 
as Sox7 and Gata5 (Figure 5A). VE cells have been shown to get integrated into 
definitive endoderm (DE) rather than being displaced by it at a later stage. The 
expressions of DE and VE markers are more prominent after the disappearance 
of MESP1 in YFP+ cells (Figure 5A), and the DE markers are more enriched in 
YFP- cells. These data suggest that MESP1 YFP+ cells contribute to both the VE 
and DE program; but after the disappearance of MESP1.  
We and others previously reported that Mesp1 transcription is under the 
regulation of canonical Wnt and T-box factors (T and Eomes) (Costello, Pimeisl et 
al. 2011, David, Jarsch et al. 2011, Li, Yu et al. 2013). New data from this study 
suggest that MESP1 regulates the expression of Eomes, Wnt3a, and Mesp1 itself. 
Together MESP1 and these early factors form a self-regulatory network which 
drives the formation of mesendoderm or a set of it. The regulation of epigenetic 
marks, MESP1 further specify downstream cardiac genes, though at a later stage 
when MESP1 itself is no longer expressed. Our study using MESP1-YFP+ cells 
reveals that MESP1 expression correlates with key mesendoderm markers. First 
heart-field markers such as Fgf8, Meis2, and Tbx5 and the second heart field 
markers such as Smarcd3, Hoxb2, Hoxa1, and Cited1 (Lescroart, Chabab et al. 
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2014) have the highest expression after day five. These observations indicate that 
MESP1-YFP+ cells are not primarily restricted to first heart field (FHF) and second 
heart field (SHF), but can give rise to another mesoderm lineage including 
hematopoietic and endoderm lineage.  
To achieve long-term cardiac cell therapy, it’s important to understand the 
regulatory network of cardiac progenitors. In particular, our group found that 
MESP1 and ETS2 were able to transdifferentiate human dermal fibroblasts into 
cardiac progenitors (Islas, Liu et al. 2012). Other combinations of transcription 
factor that successfully converted human fibroblasts to cardiomyocyte-like cells 
also included MESP1 as one of the transcription factors (Fu, Stone et al. 2013). 
This study demonstrates that MESP1 primarily drives the activation of genes 
involved in mesendoderm lineages, which potentially promotes interaction 
between different germ layers (mesoderm and endoderm) leading to cardiac, 
blood, and skeletal muscle differentiation. We believe that further elucidation of the 
genetic makeup of the MESP1-dependent regulatory elements would provide 
novel strategies in driving mesendoderm in tissue regeneration.
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3. Chapter 3 MESP1 Represses the Neuroectoderm Program by recruiting the 
PRC2 complex to a specific Ebox Variant  
 
3.1. Introduction 
 
MESP1 is a transiently expressed only during a short period of time, from 
6.5-7.5 dpc in the posterior region in embryogenesis (Saga, Hata et al. 1996). 
MESP1-Cre recombinase marked the early progenitors of the mouse cardiac 
mesoderm lineage even after its down regulation (Saga, Miyagawa-Tomita et al. 
1999, Saga, Kitajima et al. 2000, Soibam, Benham et al. 2015, Chiapparo, Lin et 
al. 2016). Key cardiac gene were still activated within lateral mesoderm tissue but 
migration anterolateral fails to initiate or is delayed. This loss of function causes 
embryonic lethality through cardia Bifida and the failure of fusion of the paired heart 
fields. MESP1-fated cells remain in the posterior region causing malformation of 
the paraxial mesoderm affecting the formation of posterior tissue development 
(Saga, Miyagawa-Tomita et al. 1999, Saga, Kitajima et al. 2000). Furthermore, 
simultaneous disruption of both Mesp1 and Mesp2 genes (dKO) led to the 
complete loss of posterior structures including heart, somites, and gut. Chimera 
analysis, however, showed that Mesp1 and Mesp2 dKO cells still contributed to 
the formation of somites and gut, but not the heart. These data indicate that Mesp1 
and Mesp2 are essential for the formation of the cardiac lineages. 
The proper formation of the lateral mesoderm that differentiates into 
cardiomyocytes, require MESP1, but the initiation of the cardiac program appears 
to be independent and can be compensated by other factors (Saga, Miyagawa-
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Tomita et al. 1999). This suggests that MESP1 may have a more important role in 
epithelial-mesenchymal transition (EMT) or a potential dominant role of repression 
of non-mesoderm lineages. Evidence of an MESP1-repressive role can be 
observed throughout publications but hasn’t been completely investigated. 
However, it has been suggested that MESP1 represses the endoderm and the 
neuroectoderm program during gastrulation (Lindsley, Gill et al. 2007, Bondue, 
Lapouge et al. 2008, Soibam, Benham et al. 2015, Chiapparo, Lin et al. 2016). Our 
recent genomic studies have suggested that MESP1 may be involved in the 
formation of the mesendoderm germ layer in higher vertebrates by activation of 
Gata4, Eomes, Wnt5a, Wnt5b, Mixl1, T, Gsc, and Wnt3, and the hematopoietic 
transcription factors, Tal1, Meis1, and Lmo2, challenging the preconception role. 
(Soibam, Benham et al. 2015). It was also shown that MESP1 does not directly 
induce the cardiac structural genes, Myh7 (b-MHC), Myh6 (a-MHC), Myl1 (MLC1f), 
Myl2 (MLC2v), and Tnnt2 (cTnT) (Soibam, Benham et al. 2015). Co-staining of T, 
Foxa2, and Sox17 with YFP show that MESP1 is associated with at least a portion 
of mesendoderm cells (Soibam, Benham et al. 2015). Transcriptome analysis of 
FACS purified endogenously activated MESP1 cells showed more repressed 
genes in comparison with activated genes (Lindsley, Gill et al. 2007, Soibam, 
Benham et al. 2015, Chiapparo, Lin et al. 2016). We showed that MESP1 primed 
the cardiac-specified genes through histone modification of target sites probably 
for later activation by downstream factors (Soibam, Benham et al. 2015).  
Here we investigate which developmental programs and gene targets are 
repressed by MESP1 during mesoderm formation and the mechanism(s) by which 
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MESP1 can exert repression. Utilizing bioinformatics and publicly available NGS 
data, I found that MESP1 targets key neuro-ectoderm GO developmental terms 
and surprisingly has a higher collection of nervous system gene targets than 
mesoderm developmental gene targets. Computational analysis of MESP1-
enriched regions indicated a bias over the two Class I ebox variant in term of 
function and the recruiting of EZH2 and the deposit H3K27me3. Using induced 
gain-of-function assay, I found that MESP1 repressed key neuro-ectoderm factors 
in mouse embryonic stem cells 
3.2. Results 
 
3.2.1. MESP1 binding enriches adjacent to multiple neuro-ectoderm regulators 
 
 To further elucidate MESP1’s repressive function during Mesendoderm 
formation, I analyzed publically available MESP1 chip-seq raw data from day four 
EB-differentiated mES cells. MESP1-binding regions were identified by using 
given peaks size, minimum distance between peaks of 50 bps, filtering based on 
local fold change of 0 and Poisson p-value of 0.0001 and target genes by assigning 
each peak with the closest transcription start site (TSS) using HOMER software 
from the Salk institute (Heinz, Benner et al. 2010). We identified 217,565 binding 
regions adjacent to 20,005 different TSS. Next, I determined the impact of MESP1 
on the total developmental process. I analyzed the gene list through DAVID online 
GO ontology analysis (Huang, Sherman et al. 2008, Huang, Sherman et al. 2009). 
I focused primarily on MESP1’s effects on developmental processes, by filtering 
the list for “development.” I discovered that a list of MESP1 gene targets has a 
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potentially large influence on the neuroectoderm developmental lineages, which 
was actually surprising considering the nature of MESP1 is involved in the 
development of the heart, head mesenchyme, and paraxial mesoderm formation 
(Figure 3.1) (Saga, Kitajima et al. 2000). 
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My analysis revealed enrichment for genes involved in the nervous system 
developmental hierarchy tree over mesendoderm terms. These terms including the 
nervous system (802 gene count and p-value 4.42x10-38), central nervous system 
(345 gene count and p-value 1.39x10-15), brain (272 gene count and p-value 
5.54x10-14), and neuron (268 gene count and p-value 8.65x10-10) (Appendix C).  
I combed through the genes with each GO term to determine if there were 
major developmental regulators. My observation revealed that many genes 
defined by GO terms associated with nervous system were MESP1 targets largely 
associated with neurogenic differentiation factors Neurod1, Neurod2, Neurod4, 
Neurod6 (Lee 1997, Franklin, Kao et al. 2001, Cho and Tsai 2004, Gao, Ure et al. 
2009, Ohtsuka and Kageyama 2010), Neurogenin, Neurog1, Neurog2, Neurog3, 
(Ma, Kintner et al. 1996, Lee 1997, Ma, Fode et al. 1999, Kele, Simplicio et al. 
2006, Seo, Lim et al. 2007, Lim and Kroll 2008, Ma, Yan et al. 2009, Ohtsuka and 
Kageyama 2010), and SRY-box containing genes Sox1, Sox2, Sox3, Sox5, Sox8, 
Sox10, and Sox11 (Wood 2002, Kan, Israsena et al. 2004, Puligilla, Dabdoub et 
al. 2010, Wegner 2011, Guo, Liu et al. 2014). These data strongly suggests that in 
addition to mesoderm-specific genes, MESP1 may directly regulate the 
neuroectoderm developmental gene pathway. 
3.2.2. The neuro-ectoderm program is repressed in mesendoderm cells 
 
Since virtually none of the key neuro-ectodermal MESP1 targets were 
expected to be activated in mesendoderm germ layer, I hypothesized,  that MESP1 
can potentially act as a repressor on neuro-ectoderm gene targets. First, I wanted 
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to test if any of the neuro-ectoderm targets of MESP1 were expressed and or 
repressed within MESP1-progenitor cells. To investigate, I cross-compared all of 
MESP1-targets with RNA-sequence data representing MESP1 enriched 
populations following hanging drops of ES cells to form embryoid bodies (EB) on 
the 5th, and 7th days. Culture conditions were described in our previous publication 
(Soibam, Benham et al. 2015).  I identified and performed separate GO analysis 
on MESP1-activated (greater than 1.5 fold) and-repressed (less than 0.5 fold) 
targets to determine the impact that MESP1 had on developmental programs 
(Figure 3.2). My analysis resulted in six clusters (A-F) with differential patterning 
determined by comparing the –log of the GO term p-value. The list of GO terms in 
each cluster can be found in Appendix B, Figure S1. 
MESP1 appeared to be a neuro-ectoderm-specific repressor as seen by 
GO terms based on p-value significance which includes nervous system (111 gene 
count and p-value 4.66x10-11), central nervous system (46 gene count and 
1.11x10-4), brain (39 gene count and 7.30x10-5), hindbrain (16 gene count and p-
value 3.65x10-5), and neuron development (40 gene count and p-value 4.50x10-5) 
(Figure 3.2 and Table 1). To measure the gain or loss of function, I analyzed genes 
involved in nervous system development by its GO term and found key neuro-
specific factors involved in development, Neurod1, Neurog1, Neurog2, Neurog3, 
Shh, Sox2, and Sox3 (Table 3.2). This comparison helped to shed light on MESP1 
role, as a direct repressor of neuro-ectoderm processes. 
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Figure 3.2. Impact of MESP1 on GO Developmental Processes. Map shows the z-score of 
the –log (P-value) of GO terms associated with upregulated and down regulated MESP1 
target Genes between YFP + and YFP – cells from Days 5 and 7 EB differentiation.  
Clustering by “Complete” Method. Lists of GO terms in cluster groups can be found in 
Appendix C .  
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Table 2.1 Gene ontology analysis of Mesp1-repressive targets 
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3.2.3. MESP1 suppresses key neuro-developmental genes 
 
While in-silico analysis that compared MESP1-targets to RNA-seq give us 
cogent correlative evidence, I next wanted to investigate whether forced MESP1 
expression would also diminish the expression of neuroectoderm targets. I 
introduced a doxycycline (DOX)-inducible tet-on expression vector of GFP-tagged 
MESP1 into mouse embryonic stem cell AB2.2. The mES cells cultured in 
monolayers were induced by DOX,  FAC sorted for YFP, and collected for each 
data time point, to guarantee  that non-induced cells were not excluded from the 
Dox-induced population (Figure3.3). Mesp1 mRNA levels increased 400 fold within 
the first six hours of Dox treatment compared to the zero time point (Figure 3.3C). 
The expression levels of Sox2, Neurod1, Neurog1, Neurog2, and Neurog3, 
showed significantly reduced mRNA levels in the Mesp1-induced population over 
non-induced cells (Figure 3.3D-H). This is in contradistinction to the rapid induction 
of factors, such as Gata6, Gata4, and Pitx2. Thus, MESP1 plays a repressive role 
on the transcription on neuro-ectodermal-dependent transcription factors, likely in 
a direct-dependent manner.  
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Figure 3.3.  MESP1 Represses Neuro Specific Gene Targets. A) Diagram of Experimental 
design. Dox inducible MESP1 mouse embryonic stem cells will be treated with a onetime 
dose of 1 ug/ml of Dox and RNA were extracted from FAC-sorted cells  at time points 6, 
12, 24, and 72 hours. B) YFP percentage collected post Dox induction for each time point. 
C-D) Real-time quantification of Mesp1, Sox2, Neurod1, Neurog1, Neurog2, and Neurog3. 
Data represents relative expression compared to undifferentiated mES cells. Error-bars
represents standard deviation of technical replicates (n=3), repeated (n=3) data not shown.
RT-qPCR show that MESP1 represses the expression of target genes with in the first 12 
hours of expression.  
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3.2.4. MESP1 and H3K27me3 binding sites enrichments overlap during early 
developmental stages 
 
Regulation of gene transcription can occur at multiple levels from the 
formation of heterochromatin for a sustained suppression to a transient regulation 
utilizing H3K27me3 through the PRC2 complex (Margueron and Reinberg 2011, 
Blackledge, Rose et al. 2015, Khan, Lee et al. 2015). Next, I wanted to determine 
if MESP1 regulated key neuro-ectodermal transcription factors were affected at 
the level of epigenetic marks by testing the deposit of H3K27me3. A genome-wide 
study of different histone modification into cardiac lineage using mouse embryonic 
stem cells has been previously characterized and deposited in public data bases 
(Wamstad, Alexander et al. 2012). First, I wanted to determine if a trend existed 
during the transition from mES cells to mesendodermal cells. I quantified 
enrichment of H3K27me3 tags over MESP1 peaks by tag density utilizing HOMER 
annotatePeak.pl program with given MESP1 peak size. I found that among the 
217,565 MESP1 peaks, 135,489 peaks had an increase in H3K27me3 enrichment, 
and 79,087 peaks had a decrease in enrichment (Figure 3.4A), which indicated a 
potential recruitment role for MESP1 for the PRC2 complex. 
I observed an overall increase in H3K27me3 modification overlapping 
Mesp1-binding sites associated with neuro-specific GO terms and a general 
decrease over Mesp1-binding sites associated with Meso-cardiac specific GO 
terms (Figure 3.4B). I observed that the chromatin landscape for MESP1 binding 
overlapped well with increased H3K27me3 enrichment on key neuronal-specific 
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developmental regulated genes, Neurod1, Neurog1, Neurog2, and Neurog3 
(Figure 3.4C-F).  
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3.2.5. MESP1 binds and recruits the PRC2 complexes 
 
Next, I asked whether MESP1 directly influences the deposit of H3K27me3 
on targeted sites through the polycomb group complex. I searched within the 
promoter and enhancer region of the highly affected neuronal gene, neurog3 and 
identified three eboxes that lie within MESP1 peaks (Figure 3.5A). To test my 
hypothesis I used our dox-inducible MESP1 expressing YFP marked mouse 
embryonic stem cells in which induced MESP1 bound and recruited to the PRC2 
complex to the binding site 1, which increased the levels of H3K27me3 
modification. Ebox site 2 showed a slight increase in MESP1 binding of the 
polycomb PC2 protein, EZH2, while H3K27me3 deposit barely showed any 
change on the third Ebox.  
I further analyzed the three different binding sites to search for any intrinsic 
difference that would suggest a bias in ebox one over the two other eboxes. I found 
that the first ebox was a dissimilar variant compared to the other two eboxes 
(Figure 3.5B-C) (CACCTG and CAGCTG). Both variants are Class I eboxes 
associated with Class A bHLH transcription factors, in which MESP1 is also a 
member (Ledent and Vervoort 2001, Jones 2004). Could MESP1 have preferential 
binding between the two variants eboxes where on is preferential for repressive 
activity? Note, ebox binding selectivity on DNA is within its bHLH domain, 
determined primarily by its basic domain.  
 
72 
 
 
 
Fi
gu
re
 3
.5
. 
R
ec
ru
itm
en
t o
f 
PR
C
2 
co
m
pl
ex
 o
n 
ne
ur
og
3 
en
ha
nc
er
s 
by
 M
ES
P1
. 
A)
 U
C
SC
 b
ed
gr
ap
h 
im
ag
e 
of
 N
eu
ro
g3
 e
nh
an
ce
rs
 a
nd
 
pr
om
ot
er
 re
gi
on
s 
sh
ow
in
g 
M
ES
P1
 D
4 
C
hI
P-
se
q 
Pe
ak
s 
ov
er
 la
pp
in
g 
w
ith
 H
3K
27
m
e3
 M
ES
 C
hI
P-
se
q 
Pe
ak
s.
 B
ox
 re
gi
on
s 
in
di
ca
te
 lo
ca
tio
ns
 
of
 e
bo
x 
m
ot
if 
wh
er
e 
PC
R
 p
rim
er
s 
wa
s 
de
si
gn
ed
 fo
r 
C
hI
P-
qP
C
R
 a
na
lys
is
. B
-D
). 
C
hI
P-
qP
C
R
 o
f I
G
G
, M
ES
P1
, H
3K
27
m
e3
, E
ZH
2,
 a
nd
 
H
2A
K1
19
ub
 o
ve
r N
eu
ro
g3
 s
ite
s 
1,
 2
, a
nd
 3
 w
ith
 th
e 
in
du
ct
io
n 
of
 M
ES
P1
 in
 m
ou
se
 e
m
br
yo
ni
c 
st
em
 c
el
ls
 fo
r 1
2 
ho
ur
s.
 E
ac
h 
si
te
 c
on
ta
in
s 
on
e 
eb
ox
 w
ith
 d
iff
er
en
t v
ar
ia
nt
s.
 N
o 
D
ox
 re
pr
es
en
ts
 n
eg
at
iv
e 
co
nt
ro
l. 
Er
ro
r b
ar
 =
 S
ta
nd
ar
d 
de
vi
at
io
n 
of
 th
re
e 
te
ch
ni
ca
l r
ep
lic
at
es
, r
ep
ea
te
d 
(n
=3
), 
da
ta
 n
ot
 s
ho
wn
. 
5k
b 
Relative Peak Intensity 
73 
 
 
Using in-silico analysis of crystal structures from different bHLH ebox DNA 
complexes, a conserved E/(RK)N(R/N) motif across the bHLH family has been 
identified to be responsible for selectivity (Atchley and Fitch 1997, Ledent and 
Vervoort 2001, Zheng, Zheng et al. 2009, Masi, Grove et al. 2011). To determine 
if MESP1 preferentially binds to one variant, I mutated lysine residue 86 within the 
binding motif (Appendix C Figure S2), which will potentially disrupt MESP1’s ability 
to bind to the phosphate backbone of the ebox, resulting in changes in DNA binding 
specificity (Masi, Grove et al. 2011).  I also generated neurog3 sites 1 (CACCTG) 
and 2 (CAGCTG) DNA probes to determine if mutant MESP1 would have 
differential binding. When each probe was incubated with a cell lysate containing 
MESP1 and mutants from 293T cells, wild type MESP1 showed preferential 
binding to neurog3 site 2, but when mutated there is a loss of affinity to site 2 and 
an increased affinity to site 1 (Figure 3.6). The ability for MESP1 to recognize and 
bind to neurog3 site 1 may require a heterodimer complex with a different bHLH. 
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Figure 3.6. Lysine 86 determines binding specificity. Northern Blot for MESP1 incubate 
with P32 labelled DNA probes of the two Neurog3 binding sites show differential binding 
between the WT, K86A, and K86R MESP1 protein. Immunoblot of Lysate used show 
even expression of MESP1 protein.  
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3.2.6. MESP1 utilizes variant eboxes based on transcriptional function 
 
 To elucidate globally the potential for MESP1 to bind different motifs, with 
differential functions, I searched in-silico within the MESP1 enriched region for 
ebox motifs (CANNTG) using HOMER motif analysis. The ebox motif has eight 
potential variants due to the flexibility of the center two bases, NN and the 
possibility that each variant may pertain to a certain function in respect to the 
different bHLH transcription factor (Soleimani, Yin et al. 2012). I searched within 
all of MESP1 peaks for all possible ebox variants. This resulted in two dominant 
variants CAGCTG made up 20.46% (p-value 1.00x10-301) of the enriched regions, 
and CACCTG made up 25.67% (p-value 1.00x10-31) similar to previously published 
data on MESP1. 
 To determine the possibility that MESP1 has preferential binding and 
differential function by ebox variants, I filtered MESP1 peaks first by locating and 
counting the different ebox variants, then I separating the count by set of peaks 
per gene. After the count is separated I grouped the counts by the fold change of 
the target gene between YFP+/- cells. I ran the same filtering flow-through with 
peaks with only H3K27me3 modification. I found that among the total MESP1 
enriched regions there is an average of 3.46 (30.39% average per gene) CACCTG 
ebox variant per gene compared to 2.76 (23.62% average per gene) CAGCTG 
ebox variant per gene (t-test paired, 5.75x10-52), indicating that MESP1 may favor 
CACCTG over CAGCTG globally (Figure 3.7).   
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Next I determined if a particular variant is a more or less abundant when the 
target gene is active or repressed, the ebox peaks were grouped accordingly with 
the RNA expression levels of annotated TSS. For enriched regions that are 
adjacent to a gene that experienced an increase in RNA expression, I also 
observed an increase in CAGCTG ebox variant per gene to 3.05 and no changes 
in the average CACCTG variant, suggestive of a bias towards CAGCTG over the 
CACCTG variant. When analyzing peaks associated with genes that are reduced 
by 0.5 fold I observed an average per peak of 3.79 (32.01% average per gene) of 
CACCTG and an average per peak appears of 2.88 (26.82% average per gene) 
of CAGCTG (t-test paired, 1.02x10-54). The increase in CACCTG over CAGCTG 
for genes that where repressed would suggest a repressive bias for CACCTG 
variant (Figure 3.7).  
 Futhermore, I asked whether the bias for CACCTG over CAGCTG in 
respect to repression is maintained when MESP1 binding overlapes with 
H3K27me3. I found that all of the MESP1 enriched regions that have overlap with 
H3K27me3 during the mesoderm stage have an average per gene count of 1.56 
for CACCTG and an average per gene count 1.22 CAGCTG. Thus, still maintaining  
a bias towards CACCTG in total MESP1-bound targeted regions (t-test paired, 
4.81x10-82) (Figure 3.6). Again to determine if the variant distribution is affected by 
gene expression, enriched regions are separated by the fold change. I found that 
MESP1-enriched regions that were associated with genes that are upregulated 
(Fold >2.0) have no significant change in ebox variant distribution seen when 
comparing all enriched regions (CACCTG = 1.89 average per gene, CAGCTG = 
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1.72, t-test paired = .10).  For genes that are repressed (Fold < 0.5), I observed an 
increase in both variants compared to the total regions, but a greater difference 
between variant (CACCTG = 1.98 average per gene, CAGCTG = 1.41 average 
per gene, and t-test paired = 8.06x10-41) (Figure 3.7). 
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Figure 3.7. Ebox variant count and percentage in MESP1-binding sites. A,B) The average 
count of CACCTG and CAGCTG ebox variant per gene in total Mesp1-binding sites. A) Total 
Mesp1-binding sites. B) Overlapping with H3K27me3. C,D) Percentage of ebox variant 
relative to the number of Peaks associated to target gene. C) Total Mesp1-binding sites. (D) 
Overlapping with H3K27me3 modification. Error bars = standard error mean of ebox variant 
per set of Mesp1-binding sites of one biological replicate. Analysis repeated with separate 
independent biological replicate, (n=2) data not shown. 
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3.3. Discussion  
 
The formation of the mesoderm germ layer is a dynamic multifactorial 
process that occurs during the expression of MESP1 and other mesendoderm 
markers, T, Eomes, and Goosecoid at 6.5 dpc in the mouse. The process itself 
required a delicate balance of multiple lineage markers at the surface and nuclear 
level that controls the transition of the epiblast into the three specific germ layers 
(endoderm, mesoderm, and ectoderm).   
In order for mesoderm to properly form, it is important that Eomes (Costello, 
Pimeisl et al. 2011), and T (David, Jarsch et al. 2011) are expressed at the proper 
time, in turn activating MESP1. The activation of MESP1 begins the EMT transition 
process that allows the migration of the nascent mesoderm from the primitive 
streak. Controlled expression of MESP1 is critical for the viability of the embryo, if 
failure of activation occurs, lethality is seen by 8.5-9 dpc due to inhibition of EMT 
transition and malformation of the heart resulting in cardia bifida (Saga, Miyagawa-
Tomita et al. 1999). Inversely, the transcript of MESP1 is present for a very short 
period of time, and the inhibition to control the expression will also result in an 
embryonic-lethality failure of proper differentiation of the posterior mesoderm layer. 
The lethality of MESP1 KO studies has established the importance of completely 
understanding the mechanism and role it plays during mesendoderm formation 
and maturation.  
 The repression of the epiblast/ectoderm signature during gastrulation is 
important for the proper formation of both the endoderm and mesoderm layers and 
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our evidence suggests that MESP1 may play a role, in addition, the importance of 
properly inhibiting the epiblast/ectoderm differentiation factors hasn’t been well-
studied. During embryogenesis, MESP1 progenitor cells contribute to the cranial-
cardiac mesoderm and the paraxial mesoderm tissues, which are directly adjacent 
to the notochord and the neuro-fold.  
 Our previous finding analyzing the transcriptome of MESP1 progenitor cells, 
revealed a potential for MESP1 to act as a transcriptional repressor on non-
mesoderm lineages, in addition, recent findings show that MESP1 can indirectly 
regulate the neuro-ectoderm program through the expression of miRNA’s that 
block the expression of Celf1 (Shen, Soibam et al. 2016). A re-interpretation of our 
previous findings has shed light on MESP1’s direct potential to regulate the neuro-
specific ectoderm program. This may have been overlooked in previous studies 
due to its implication in the formation of the heart, and that lack of contribution of 
MESP1-fated cells into neuro-ectoderm lineages.  
 The potential dual function of MESP1 and the motif analysis of two 
predominate ebox variants lead us to believe that its function is dependent on the 
variant.  Our filter analysis based on MESP1-enriched regions relative to RNA 
expression levels between MESP1-expressing and-non expressing cells of 
adjacent genes suggest that MESP1 utilizes the CACCTG variant over CAGCTG 
to repress gene targets. Further filtering utilizing histone modification H3K27me3 
for repression and H3K27ac for activation resulted in an inverse relationship 
relative to its chromatin state. MESP1-binding to neurog3 at CACCTG in site 3 
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recruited EZH2 to that location and deposited methyl groups to Histone 3 lysine 
27. Co-immunoprecipitation of MESP1 and the PRC2 complex will determine if 
MESP1 directly interacts with a component of the complex. However, no evidence 
was observed. We also chipped for PRC1 complex ring1 and H2A119ub to 
determine if the binding region is signaled to convert into heterochromatin during 
the expression of MESP1. However, we observed no deposit which would indicate 
that MESP1 only can only transiently repress transcription with the deposit of 
H3K27me3. The conversion of euchromatin to heterochromatin may require 
downstream factors that replace MESP1 after its expression is reduced.  
The failure to repress MESP1’s neuro-ectoderm targets through the PRC2 
complex may cause malformation in the development in the neuro-fold, neuro-
tube, and the axial, paraxial mesoderm, due to its proximal location during 
embryogenesis. Further studies on the effects of MESP1 on the PRC2 complex 
will need to be investigated. In addition, due to the early lethality of MESP1 KO, 
and failed migration to form the cardiac and crania-mesoderm, improper 
conversion of crania-mesoderm into notochord or neuro-fold in the anterior region 
cannot be studied.  
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4. Chapter 4 Overview 
 
It is important to understand the reductive nature of MESP1 and how other 
transcription factors may interact and contribute regulatory activity in directing 
somatic and stem cell reprogramming. It is also important to understand its impact 
on biological or developmental processes but the mechanism of transcription 
factors like MESP1 on a global level with whole transcript and DNA-binding 
sequence analysis. It is critical not to rely heavily on the gain of function analysis 
with forced expression that can result in many false positives. A holistic approach 
is better to determine transcription factors targets endogenously and their effects 
during differentiation through lineage tracing during differentiation. The focus of 
this study was to determine MESP1’s endogenous function, its effects on the 
cardiac program and how it manipulates the chromosome landscape at target 
sites.  
 At the beginning of this study, MESP1 was determined to be at the top of 
the hierarchy tree in terms of initiating the cardiac program, with subsequent 
activation of Mef2c, Nkx2.5, Myod, Hand2, Gata4, and Gata6. (Figure 2.2, 2.4, 2.4, 
3.2, and Table 2.1)  (Saga, Miyagawa-Tomita et al. 1999, Kitajima, Takagi et al. 
2000, Saga, Kitajima et al. 2000, Lindsley, Gill et al. 2007, Bondue, Lapouge et al. 
2008). However, the comparison between the gain of function investigations of 
MESP1 resulted in conflicting conclusions, which leads us to determine if it directly 
or indirectly activates the cardiac gene program. (Lindsley, Gill et al. 2007, Bondue, 
Lapouge et al. 2008). The hurdle to overcome was to distinguish whether MESP1 
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directly or indirectly regulates target cardiac genes and its effects on the whole 
developmental program. It is accepted that MESP1 can cell-autonomously activate 
the cardiac program in undifferentiated and differentiating mES cells by activating 
the core cardiac program. However, the studies done previously on MESP1’s 
regulatory role is subject to potential artifacts from transient over expression which 
is evident compared to these findings.  
This study shows that MESP1-marked cells eventually activate the core 
cardiac program but after 48 h after the activation and degradation of MESP1 
(Figure 2.4). This is evident from in vivo embryo and mES cell EB differentiation 
studies conclude that the expression of mRNA of MESP1 is quickly down-
regulated after expression on day four of EBs and in the lateral migration of 
mesoderm cells during embryogenesis (Figure 2.1).  
This gap in time between MESP1 expression and the activation of the core 
cardiac program (Figure 2.4C, D, 2.5A) showed that the activation is, in fact, 
indirect. And the potential process in which the signal is relayed through 
epigenetics is evident, but, however, not conclusive.  (Figure 2.6 and Figure 3.4). 
The limitation of this study is that it is correlative between the stages of mES cell 
differentiation and does not determine causality. It would be necessary to utilize 
both gain and loss of function to properly determine causality in respect to MESP1 
and changes in epigenetic through chromatin remodeling.  
 In addition, it is evident that MESP1 is more than just an activator of the 
core cardiac program and initiator of EMT, which was the focus of MESP1’s 
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function in the past decade, but a repressor of non-mesoderm programs, and a 
chromosome modifier that it has a lasting effect that transcends its presence. The 
function of MESP1 has been evident in previous literature, showing that it can 
affect the expression of key endoderm factors like Foxa2 and Sox17 (Bondue, 
Lapouge et al. 2008). It has been suggested that MESP1 may repress endoderm 
formation during gastrulation, however, our evidence suggests that this isn’t 
completely true (Figure 2.4, Figure 2.5, and Appendix B Figure S4). Many early 
endoderm developmental programs are activated within MESP1 marked cells and 
co-staining show the expression of T, Foxa2, and Sox17 with YFP. 
The repressive function of MESP1 is further expanded in this study and the 
mechanism through the PRC2 complex that is used. We found that during 
differentiation, MESP1-marked cells show a decrease in neuro-ectoderm factors 
which is expected, however, the analysis of all of MESP1’s potential targets show 
an overwhelming association with neuro-ectoderm developmental gene targets 
rather than those representing mesoderm and endoderm-expressed genes. This 
finding is supported by Lindsley et al. (Lindsley, Gill et al. 2007), utilizing DKK1 
and a WNT inhibition which increased the expression of neuronal factors in mES 
cells repressed by MESP1.  
Furthermore, dual roles of MESP1 lead us to investigate potential DNA 
binding preferences. In this study, I revealed new supporting evidence that 
individual ebox DNA motifs, may have Mesp1 binding favorites, biased with one 
variant that coincides with function. The notion that MESP1 may utilize a specific 
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ebox variant opens the door to new research in regards to understanding the 
complex nature of all bHLH factors. 
It is evident from this study that MESP1 changes binding affinity depending 
on the molecular makeup of the cell. In 293T cells the expression of only Mesp1 
allowed for the binding to CAGCTG as a homodimer, but when K86 of MESP1 was 
mutated to alanine and arginine, the mutation of MESP1 altered affinity to 
CACCTG (Figure 3.7). However in mouse ES cells, AB2.2, MESP1 can bind to 
neurog3 site 1 that contains the CACCTG ebox variant and recruit the PRC2 
complex and deposits methylation onto K27 of histone 3 (Figure 3.5).  This 
suggests that in order to achieve MESP1 binding and recruitmenting of the PRC2 
complex onto site 1 of the neurog3 site, MESP1 likely heterodimerizes with a 
different bHLH factor that is present in mES cells but not in 293T cells. In addition, 
bHLH transcription factors act in tandem with other bHLH factors and primary 
function as a heterodimer. This heterodimer cofactor potential may disrupt Lysine 
86 binding to the phosphate backbone of the DNA helix allowing for increased 
affinity for ebox binding. (Skinner, Rawls et al. 2010, Masi, Grove et al. 2011). 
A phylogenetic analysis of mouse bHLH factors has divided all known 
factors into groups based on total sequence similarities. MESP1 belongs to a 
family identified as Clades C. This family contains MESP2, FIGLA, MYF6, MYOG, 
MYOD1, MYF5, MXD3, MAD, MXL1, MXD4, MAD4, and TRAFP4. Clade C factors 
have the propensity to co-factor with Clade D factors, which include, TCFL4, MNT, 
SREBF1, SREBF2, and MAX. In addition, the lysine 86 residue found in MESP1 
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that determine binding specification can also be found in other Clade C MAD 
factors, which are known to co-factor with Clade D MAX factors, to repress target 
genes (Masi, Grove et al. 2011). This leads to the possibility that MESP1, when 
co-factored with MAX factors, will bind and repress target genes by recruited the 
PRC2 complex. Further investigation is required to show that this is, in fact, the 
case when it comes to MESP1 repression.  
With the improvement of ChIP and sequencing technology, is has become 
increasingly possible to analyze the DNA binding sites of various transcription 
factors like MESP1 from a relatively small sample size. To understand a 
transcription factors unbiased or natural binding sites, analysis of endogenous 
expressing protein is critical to identify its function. In addition, an added benefit in 
studying a transcription factors in its endogenous level and proper stage in 
development is that the necessary co-factors that is required for a function that 
may not be present in model systems like 293T. This, however, does not discredit 
the majority of findings using forced expression but should be approach with much 
skepticism.  
I conclude from my study that; 1) MESP1 indirectly activates the core 
cardiac program, Nkx2-5, Mef2c, Hand2, and Myod1 potentially through histone 
modification by H3K27acetylation and relays the activating signal through 
downstream factors, Hand2, Twist, and Gata factors, 2) MESP1 directly represses 
the non-mesodermal programs like neuro-ectoderm through the PRC2 complex 
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resulting in the deposit of H3K27me3. 3) MESP1 directs function utilizing different 
ebox variants through potential co-factors.  
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5. Appendix A Materials and Methods 
 
Immunostaining: For immunostaining of differentiated cardiomyocytes, 
chamber slide cultures were fixed in 4% paraformaldehyde for 10 minutes, then 
permeabilized in 0.1% Triton X-100 in phosphate buffer saline (PBS) for 30 
minutes at room temperature. Next, the slides were incubated in blocking buffer 
(10% normal goat serum, 0.1% Triton X-100 in PBS) for 30 minutes at 370C, then 
in 1:100 anti-a-actinin antibody diluted in blocking buffer at 40C overnight. The 
slides were next incubated in 1:500 fluorescein isothiocyanate (FITC)-conjugated 
anti-mouse antibodies for 90 minutes at room temperature. Finally, the slides were 
mounted in DAPI-containing mounting media and documented under a Nikon 
fluorescent microscope. 
For co-staining of T, Foxa2, or Sox17 with YFP, day five EBs were used, 
and a similar staining procedure as above was followed. The primary antibodies 
used were T (Santa Cruz Biotech, H-210), Foxa2 (Santa Cruz Biotech, H-150), or 
Sox17 (Santa Cruz Biotech, H-130) together with biotin-conjugated anti-GFP 
(Novus). The secondary antibodies used were FITC-conjugated goat anti-rabbit 
(Molecular Probes) and allophycocyanin (APC)-conjugated streptavidin (Molecular 
Probes).   
Karyotype: Karyotyping was performed by The Texas Children’s Cancer 
Center Cytogenetic Research Lab using the Giemsa staining method on 
metaphase chromosomes.  
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Western Blot: Samples were lysed in radio immunoprecipitation assay 
(RIPA) buffer supplemented with protease inhibitors (P8340, Sigma Aldrich) and 
the protein concentrations were determined by BCA Protein assay kit (PI-23225, 
Thermo Scientific). The samples were denatured by boiling for five minutes with 
NuPAGE LDS Sample Buffer (NP0007, Life Technologies), and subjected to 
electrophoresis with Novex NuPAGE system.  Then the proteins were transferred 
to polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were 
blocked with 5% TBST-milk before treatment with the primary antibody and 
followed by horseradish peroxidase (HRP) conjugated secondary antibody 
incubations. Enhanced chemiluminescence (ECL, NEL104001EA, Perkin Elmer) 
reagent was used to visualize the targeted protein. The antibodies used were as 
follow: MESP1 (rabbit polyclonal, Bethyl Lab) and GAPDH-HRP (sc-20357-HRP, 
Santa Cruz Biotechnology).  
RNA Isolation and qRT-PCR: In the UH3 characterization studies (Appendix 
B Figure S1), unsorted EB RNA was isolated using Trizol (Life Technologies). RNA 
was extracted using a Direct-zol RNA MiniPrep kit from Zymo Research.  Following 
RNA isolation, RNA was quantified using a Nanodrop and cDNA was synthesized 
using qScript cDNA Supermix from Quanta Bioscience. QPCR was performed 
using SYBR Select Mast Mix following the Manufacturer’s guidelines.  Primers 
were from the Primerbank database (Wang, Spandidos et al. 2012) unless 
specified otherwise.  
The primer sequences with their respective Primerbank ID were:  
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T-forward 5’ GCTTCAAGGAGCTAACTAACGAG 3’ 
T-reverse 5’ CCAGCAAGAAAGAGTACATGGC 3’, 6678203a1;  
MESP1-forward 5’ GCTCGGTCCCCGTTTAAGC 3’ 
MESP1-reverse 5’ ACGATGGGTCCCACGATTCT 3’, 254588103b1;  
Gata4-forward 5’ CACGCTGTGGCGTCGTAAT3’ 
Gata4-reverse 5’ CTGGTTTGAATCCCCTCCTTC 3’, 110681730b3;  
Tbx5-forward 5’ TGGCTGAAGTTCCACGAAGTG 3’ 
Tbx5-reverse 5’ TTTGGGATTAAGGCCAGTCAC 3’, 229577242b2;  
Mef2c-forward 5’ ATGCCATCAGTGAATCAAAGGAT 3’ 
Mef2c-reverse 5’ GTGGTACGGTCTCCCAACT 3’, 13384624a1;  
Nkx2.5-forward 5’ GACAAAGCCGAGACGGATGG 3’ 
Nkx2.5-reverse 5’CTGTCGCTTGCACTTGTAGC 3’, 6679068a1;  
Sirpa-forward 5’ CACGGGGACAGAAGTGAAGG 3’ 
Sirpa-reverse 5’TGCAGTTGAGAATGGTCGAATC 3’, 6671640a1;  
Cxcr4-forward 5’ GAAGTGGGTTCTGGAGACTAT 3’ 
Cxcr4-reverse 5’ TTGCCGACTATGCCAGTCAAG 3’, 6756460a1; 
Flk1-forward 5’ TTTGGCAAATACAACCCTTCAGA 3’ 
Flk1-reverse 5’ GCAGAAGATACTGTCACCACC 3’, 27777648a1;  
Pdgfra-forward 5’ GGAGACTCAAGTAACCTTGCAC 3’  
Pdgfra-reverse 5’ TCAGTTCTGACGTTGCTTTCAA 3’, 134032015c3;  
Alcam-forward 5’ CTCGTTGCTGGTGTCGTCTA 3’ 
Alcam-reverse 5’ AATCCGCTCCTCTCTTAGGC 3’  
Gapdh-forward 5’ AGGTCGGTGTGAACGGATTTG 3’  
Gapdh-reverse 5’ TGTAGACCATGTAGTTGAGGTCA 3’, 6679937a1.  
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Primers Designed by Blast-primer (NCBI) 
Sox2 forward 5’ GCGGAGTGGAAACTTTTGTCC 3’ 
Sox2 reverse 5’ CGGGAAGCGTGTACTTATCCTT 3’ 
Neurog3 forward 5’ CCAAGAGCGAGTTGGCACT 3’ 
Neurog3 reverse 5’ CGGGCCATAGAAGCTGTGG 3’ 
Neurod1 forward 5’ ATGACCAAATCATACAGCGAGAG 3’ 
Neurod1 reverse 5’ TCTGCCTCGTGTTCCTCGT 3’ 
Neurog1 forward 5’ CCAGCGACACTGAGTCCTG 3’  
Neurog1 reverse 5’ CGGGCCATAGGTGAAGTCTT 3’  
Neurog2 forward 5’ AACTCCACGTCCCCATACAG 3’  
Neurog2 reverse 5’ GAGGCGCATAACGATGCTTCT 3’  
 
MESP1 ChIP-qPCR primers Designed by Blast-primers (NCBI) 
Neurog3 Site1 forward 5’ GGAGCACCCGAGGTCTTTAT 3’ 
Neurog3 Site1 reverse 5’ GAAGAGGCGTGGGTTCAACA 3’ 
Neurog3 Site2 forward 5’ GTGGGGACAGATAAGGCGAG 3’ 
Neurog3 Site2 reverse 5’ TCATTCAAGAGCGCACAAGC 3’ 
Neurog3 Site3 forward 5’ CTGGCACGCTTTATCTGCTC 3’ 
Neurog3 Site3 reverse 5’ CCTGCCCTTTGTCCGGAAT 3’ 
 
The RNA of AB2.2 was isolated by RNeasy Mini kit (74104, Qiagen) and 
quantified using Nanodrop. The cDNA was synthesized using the M-MLV reverse 
transcription kit (28025-013, Life Technologies). Quantitative real-time PCR was 
carried out using Brilliant II SYBR Green QPCR Master Mix (600828, Agilent 
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Technologies). The primers used for MESP1 and Gapdh were the same primers 
as indicated. In the remaining RNA-Seq and ChIP-Seq studies, RNA was isolated 
from undifferentiated, and FACS sorted UH3 cells at day 5-8 post- differentiation. 
Both the positive and negative populations were used for transcriptome analysis. 
RNA was extracted from 250,000 cells for each group using the RNAeasy kit from 
Qiagen following the manufacturer’s recommended procedure. Following isolation, 
the RNA was quantified on a Nanodrop. 
RNA-Seq Library Preparation: A total of 100 ng of the isolated RNA was 
used for generating the library for next-generation sequencing using Illumina’s 
HiSeq platform at MD Anderson DNA core facility. Libraries were prepared using 
the ScriptSeq Complete Gold kit from Epicentre (Cat. No. SCL24EP) following the 
manufacturer's recommended procedure for low input starting material. Final 
libraries were quantified using the pico-green quantification kit from Promega using 
Promega’s Quantifluor fluorometer. 
RNA-Seq Data Processing: RNA-Seq reads were aligned to the mouse 
genome using tophat with parameters: -p 8 --read-mismatches 2 --b2-L 20 -g 5. 
Reads that mapped to multiple locations of the genome were discarded before 
downstream analysis. An annotated list of known transcripts (mm9 UCSC refseq 
genes) was used for a final set of the transcriptome. The abundance and number 
of raw fragments aligned to each gene were computed using cufflinks (Trapnell, 
Williams et al. 2010). The abundance of each gene was expressed as FPKM 
(Fragments Per Kilobase of transcript per Million mapped reads).  
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To obtain differentially expressed genes between two conditions, we used 
DESeq (Anders, Anders et al. 2010). The raw counts mapped to a transcript were 
obtained using htseq-count and were used as inputs to the DESeq tool. To remove 
genes with low expression profiles, we included only the ones with a total aligned 
fragment count across all three biological replicate samples greater than five. We 
used P-value of less than 0.05 as the criteria to determine differentially expressed 
genes between two conditions. 
To perform hierarchical clustering of genes associated with different germ 
layers, we obtained genes which were annotated under direct GO terms – 
mesoderm development, endoderm development, and heart development. The 
robust z-score was computed for each gene using its FPKM values across ES, 
days 5, 6, 7, and 8 of YFP+ cells. We used cosine similarity metric to quantify the 
similarity between any two genes. Clustering was performed using R (http://www.r-
project.org/). 
Chromatin Immunoprecipitation and Library preparation for Next Generation 
Sequencing:  
MESP1 and Histones ChIP: 
H3K4me3 ChIP was performed in purified day five UH3 YFP+ cells. MESP1 
ChIP was performed in E14 mES cells. E14 cells have wild-type MESP1 alleles 
and higher MESP1 expression, which produced consistently high-quality ChIP in 
pilot experiments.  
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Embryoid bodies (EBs) were collected on day four for MESP1 ChIP-seq.  
Briefly, the collected EBs was treated with formaldehyde for chromatin cross-
linking. Chromatin DNA of the treated cells was fragmented by sonication. The 
DNA was run on a 1% agarose gel in 2 μL and 4 μL aliquots to check the size of 
the fragments. Then 1 mL of the nuclear extract from about 1x106 (starting material 
for hanging drops) cells was used for immunoprecipitations.  Portion of the 
fragmented DNA supernatant was saved for input and the remainder was 
incubated with MESP1-C antibody H3K27me3 (diagenode), H2AK119ubq 
(digenode), and EZH2 (diagenode).  After overnight incubation, the antibody/DNA 
complex was immunoprecipitated down using Protein G Agarose beads.  Following 
extensive washing, DNA/protein was eluted, and DNA was separated from the 
protein complex through digestion with proteinase K and purification using 
diagenode iPURE kit. The polyclonal antibody against the C-terminus of mouse 
MESP1 was produced in rabbit using peptide immunogen 
SSDMLALLETWTPPQEWPPA. It was purified by affinity chromatography, and 
validated by enzyme-linked immunosorbent assay (ELISA), western blot (Figure 
S11A), and immunoprecipitation (Figure S11B). Similar procedures were followed 
for H3K4me3 ChIP, while samples were from sorted day five UH3 YFP+ cells, and 
the antibody was purchased from cell signaling (9727s). 
70 ng of the ChIPed DNA or input DNA was used for Illumina sequencing 
library generation. First, end repair of ChIP DNA was carried out using T4 DNA 
polymerase, T4 polynucleotide kinase, and DNA pol I Klenow fragment. Then a dA 
tail at the 3’ end followed by ligation with illumines Tru-seq index adaptors.  The 
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ligated fragments were amplified using limited cycles of PCR.   The size and 
distribution of the amplified library was measured by agarose gel for quality control.  
The amplified DNA was quantified with the Quant-iT PicoGreen dsDNA Kit 
(Invitrogen) and diluted to 10 nM.  The constructed libraries were sequenced with 
Solexa sequencing technology at the University of Houston using Illumina’s high-
throughput Genome Analyzer.  The input containing the entire genome was used 
as a control, and each library was run using a single lane.  
Numerous times were attempted to pull out MESP1-bound chromatin using 
MESP1-Cre;Rosa26-YFP mES line (UH3) using ChIP-Seq. However, the data did 
not show enrichment indicating few MESP1-bound DNA fragments and hence did 
not passed the ChIP-Seq data standards laid out by the ENCODE project. This is 
likely due to the heterozygous MESP1 allele or other intrinsic cell line variations. 
The E14 line had the same genetic background, and we were able to generate 
high-quality data from these cells. Thus, the timing was carefully selected for 
sample collection when MESP1 was expressed at the highest level. 
ChIP-Seq data processing: All the ChIP-Seq data were aligned to the 
mouse reference genome using bowtie with program options: -t -v 2 -a -m 1 --best 
--strata. Reads, which mapped to multiple locations in the genome, were discarded 
before subsequent analysis.  
Histone modification patterns display broad peaks. Therefore, we used 
MACS2 (https://github.com/taoliu/MACS/) with the “--broad” option to process the 
H3K4me3 ChIP-Seq data. A stringent FDR threshold of 0.01 was used to obtain 
the final set of peaks. To compute the H3K4me3 signal or enrichment for a gene, 
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we considered an interval that flanks 2000 bp upstream and downstream of the 
transcription start site of the gene. The read depth at every position within the 
intended interval was computed. The sum of the read depth across the interval 
was the H3K4me3 signal. 
Downstream analysis of ChIP-Seq data: To perform downstream analysis 
of ChIP-Seq data, we used HOMER to assign gene-specific information (nearest 
gene, distance from nearest TSS) to each peak based on the peak’s nearest 
annotated TSS. We also classified peaks into promoter (-1kb to +1kb within the 
TSS), intergenic, intron, and exon. The sequences representing the peaks were 
extracted from the mouse genome. The background set of sequences (containing 
matching GC contents to the peaks) generated by HOMER was used to compare 
the original peak sequences. The binary response, y, indicating a motif is present 
(y=1) or absent (y=0) in a peak was posed as a regression problem: y ≈ a + xb + 
yc, where x indicates the frequency of the motif in the peak, y is the GC content, 
and a is constant. We used FIMO to compute the frequency of motifs from JASPAR 
database in the peaks using a P-value threshold of 0.0001. FIMO was applied to 
both the sequences representing the actual peaks and the background set. 
Regression analysis using motif counts and GC content in the actual peak 
sequences and the background set yielded two metrics: P-values and z-values. 
Motifs were ranked according to z-values; starting from the one with the highest z-
score. This same procedure was used to compute enrichment for different variants 
of ebox in the MESP1 peaks. 
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To identify direct targets, we tested for differential expression from the RNA-
Seq data using edgeR (p-value < 0.05). 
Enriched GO terms were obtained using DAVID on the set of genes which 
are nearest to the peaks and using mouse genome as the background set of 
genes.M. 
H3K27me3 Histone modification ChIP-Seq fastq data for GSE47950 was 
obtained from the GNomEx database under accession numbers 44R and can be 
found: https://b2b.hci.utah.edu/gnomex/ by the guest login.  ODS 
ESC Culture and Differentiation 
MESP1Cre/1; Rosa26EYFP/+ reporter (UH3) cells were established by the 
conventional blastocyst outgrowth method. AB2.2 ESCs were used as a control. 
Cells were cultured in knockout DMEM (GIBCO, NY, 
http://www.lifetechnologies.com/us/en/ home/brands/gibco.html) with 15% stem-
cell grade fetal-bovine serum (Atlanta Biologicals, GA, https://www.atlantabio. 
com/), 1% antibiotic/antimitotic (GIBCO, NY), 100 lM Bmercaptoethanol, 2 mM l-
glutamine (GIBCO, NY), and supplemented with 1000 U/ml of leukemia inhibitory 
factor (LIF) to maintain pluripotency. The media was changed daily, and passaging 
of the cells was done every three days. Before differentiating, the UH3 cells were 
FACs sorted to remove all YFP+ cells generated from low-level spontaneous 
differentiation. AB2.2 and UH3 cells were differentiated using the hanging drop 
method. Briefly, 20 ul drops of LIF free ES media containing 400 cells were placed 
on the lid of a square petri dish. The bottom of the dish was filled with 5 ml 
98 
 
 
autoclaved water, and the drop-containing lid was inverted over the dish. The 
embryoid bodies were plated on day five to gelatin-coated dishes. LIF-free ES 
media was refreshed every three days. For initial differentiation characterization 
studies, the ES media was supplemented with 10 ng/ml human BMP-4 (Peprotech, 
NJ, https://www.peprotech.com/). 
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6. Appendix B Chapter 2 Supplement 
 
Published Work 
 
Soibam, B., Benham, A., Kim, J., Weng, K. C., Yang, L., Xu, X., Robertson, M., Azares, A., 
Cooney, AJ., Schwartz, R.J., Liu, Y. (2015). Genome‐Wide Identification of MESP1 
Targets Demonstrates Primary Regulation Over Mesendoderm Gene Activity. 
STEM CELLS, 33(11), 3254‐3265.  
  
Figure S1: MESP1-lineage cells give rise to beating cardiac myocytes. (A) Phase contrast 
image of undifferentiated UH3 cells at 100x magnification. (B) Karyotype analysis of UH3 cells 
showing a normal male karyotype. (C) Representative images of FACs sorted YFP+ UH3 
cells staining for well-formed sarcomeres by anti-alpha-actinin antibody. (D) Beating cluster 
(red circled) co-localized with YFP+ cells signal. The cells within the area circled by a blue 
line was YFP- and did not participate in spontaneous beating. Scale bars are 500 μm. 
100 µm 
100 µm 
500 µm 
500 µm 
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Figure S2. qRT-PCR characterization of lineage-representative genes in UH3 cells. UH3 
cells were aggregated and differentiation in hanging drops. At the indicated days (days 0, 
1, 2, 3, 4, 5, 6, 7 and 8), EBs were harvested, RNA isolated, and QPCR performed to 
measure representative gene expression. 
101 
 
 
 
Figure S3. H3K4me3 ChIP-Seq for MESP1-YFP+ cells. (A) and (B) H3K4me3 ChIP-Seq data pass 
ENCODE ChIP-Seq data quality standard. Cross-correlation curve peaks approximately at 200 bp 
for day five YFP+ and mES cells. ChIP-Seq quality metrics such as relative strand correlation 
(RSC), normalized strand correlation (NSC) were above the standard suggested by ENCODE. (C) 
and (D) Histogram of H3K4me3 peaks with respect to distance from the nearest TSS. 
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Figure S4: Expanded Heatmaps of genes in main Figure 2E. Expression profiles of RNA-seq
(FPKM) data (days 0 (mES cells), 5, 6, 7, 8 post differentiation YFP+ cells) of genes associated 
with Heart, mesoderm and endoderm development are shown. Heatmaps of z-score of fold changes 
were split because of large number of genes.   
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Figure S4 Continued 
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Figure S4 Continued 
105 
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Figure S4 Continued 
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Figure S4 Continued 
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Mesp1 Background Mesp1 Background p-value
CAGCTG 11248 7164 26% 17% 34.3 <2e-16
CACGTG 6749 4131 16% 10% 26.8 <2e-16
CACCTG 9652 6745 22% 16% 25.6 <2e-16
CACATG 3714 2267 9% 5% 21.4 <2e-16
CAGGTG 9572 7802 22% 18% 15.2 <2e-16
CATGTG 3699 2790 9% 6% 13.8 <2e-16
CACTTG 3750 3010 9% 7% 10.7 <2e-16
CAGATG 4072 3353 9% 8% 10.5 <2e-16
CATCTG 4105 3618 9% 8% 7.57 3.67E-14
CAACTG 2554 2160 6% 5% 7.17 7.81E-13
CAAGTG 3566 3152 8% 7% 6.57 4.98E-11
CAGTTG 2536 2341 6% 5% 4.15 3.34E-05
CAAATG 1147 1429 3% 3% -4.2 2.64E-05
CATTTG 1226 1591 3% 4% -5.45 5.08E-08
CATATG 538 818 1% 2% -5.81 6.36E-09
CAATTG 596 917 1% 2% -7.37 1.74E-13
Peaks # %
Ebox Variant Score
Figure S5. Ebox variant enrichment in MESP1 peaks. The variants colored in light blue (Note 
the positive scores) are enriched in MESP1 peaks compared to background. There are some 
variants, which occupy less than 10% of the MESP1 peaks. These variants might be less 
preferred than the other variants. 
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Figure S6. Top 10 motifs in MESP1 peaks identified by HOMER (A) and FIMO (B). 
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Figure S7. Increase in H3K4me3 modification associated with MESP1-activated 
targets. We computed the normalized ChIP-Seq reads (both in mES and day five 
MESP1 YFP+ cells) which overlap with a 4 kb interval centered at the TSS of the 
MESP1 direct targets. The difference in the H3K4me3 signal was computed by 
subtracting the H3K4me3 signal in mES cells from that in day five MESP1 YFP+ 
cells. MESP1-activated targets showed significant increase compared to repressed 
targets in H3K4me3 signal from mES to day five YFP+ cells. 
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Figure S8. GO enrichment of MESP1-activated targets in YFP+ and YFP- cells. 
The MESP1-activated targets were compared at different time points (day 5, 6, 7 
and 8) for differentially expression between YFP+ and YFP- cells. The heatmap 
shows enriched gene ontology terms for two groups of MESP1-activated targets. 
Group I comprises of all targets which were strictly upregulated in YFP+ cells 
during course of differentiation, group II represents targets which were strictly up-
regulated in YFP- cells during the course of differentiation. The color scale is 
shown in –log10 P-value. 
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Figure S9. MESP1 induces genome-wide H3K27ac histone modification. (A) Increase in 
H3K27ac  signal at MESP1 peak regions from mES to mesoderm cells. At all the MESP1 
peak locations, the difference between H3K27ac  ChIP signal in mesoderm and mES cells 
were plotted as a function of log2 (normalized read count). The horizontal blue line 
represents zero difference. Majority of the data points lie above the light blue line. (B) At all 
the MESP1 peak locations, H3K27ac  ChIP signal in mesoderm cells and mES cells were 
plotted. Majority of the data points lie above the light blue line indicating an increase in 
H3K27ac  modifications (increase in mesoderm cells compared to mES cells). 
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Figure S10. Comparison of MESP1 DNA binding regions identified by ChIP-PCR and ChIP-Seq. 
We compiled a list of DNA regions which were tested for MESP1 enrichment using ChIP-PCR as 
described in a previous study. The primers representing these regions are shown in the first column 
of the table. An ‘x’ in the second column indicates positive results in ChIP-PCRs. In the fourth 
column of the table, an ‘x’ indicates an overlap (at most at a distance of 500 bp) with an MESP1 
ChIP-Seq peak in this study. About 25% of the MESP1 enriched regions identified in the published 
ChIP-PCR were detected by our MESP1 ChIP-Seq data. 
 
 
 
 
cFoxA2AF x Foxa2
cFoxA2BF Foxa2
cFoxA2CF Foxa2
cFoxA2DF x Foxa2
cG4AF Gata4 X
cG4BF x Gata4
cG4CF x Gata4
cG4DF x Gata4
cG4EF Gata4 X
cG4FF Gata4
cG4GF Gata4
cGSCAF1 Gsc
cGSCBF1 x Gsc
cGSCCF1 Gsc
cHand2AF1 Hand2
cHand2BF1 Hand2 X
cHand2CF1 Hand2
cHand2DF1 x Hand2
cHand2EF1 x Hand2
cHand2FF1 x Hand2
cHand2GF1 Hand2
cHand2HF1 Hand2
cHand2IF1 Hand2
cHand2JF1 Hand2
cHand2KF1 Hand2
cHand2LF1 x Hand2
cHand2MF1 x Hand2
ChIP-PCR result
shown in (2) Gene Overlap with this Study MESP1 ChIP-Seq PeaksPrimer ID from previous study (2)
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Figure S10. Cont. 
 
 
 
 
 
 
 
 
cM1AF MESP1 X
cM1BF x MESP1
cM1CF MESP1
cM1DF MESP1
cMyocAF Myocd
cMyocBF x Myocd X
cMyocBF x Myocd X
cMyocCF x Myocd X
cMyocCOF Myocd
cN24AF x NKx2-5 X
cN25BF Nkx2-5 X
cN25C NKx2-5
cN25D x NKx2-5 X
cN25E x NKx2-5 X
cRply2AF x RIPPLY2
cRply2BF RIPPLY2
cRply2CF x RIPPLY2
cRply2COF x RIPPLY2
cSox17AF2 Sox17
cSox17BF2 Sox17
cSox17cF2 x Sox17
cSox17DF2 x Sox17
cSox17EF2 Sox17
cBrachAF x T X
cBrachBF T X
cBrachCF x T
cDkk1AF x Dkk1
cDKK1BF x Dkk1
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Figure S11. MESP1 antibody validation. (A) MESP1-C antibody detected a prominent 
band of predicted mass in western blot analysis. Lysate was prepared in 293T cells 
expressing ectopic mouse MESP1. (B) MESP1-C antibody can be used to 
immunoprecipitate MESP1. Lysate was prepared from mES cells fixed with 1% PFA to 
mimic ChIP conditions and expressing ectopic mouse MESP1. MESP1-C antibody was 
used in IP followed by western blot. 
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7. Appendix C Chapter 3 Supplement 
 
MESP1 Represses the Neuro-ectoderm Program by recruiting the PRC2 complex 
to specific ebox Variant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. List of GO terms from heatmap in chapter 3 Figure 3.2. 
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Figure S2. Diagram of Mesp1 mutation and location. Lysine 86 is located in the conserved 
E/(RK)N(R/N) motif. Mutation into alanine eliminates interaction with phosphate back bone. 
Mutation into Arginine potentially preserve interaction but change structural positioning 
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